image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
f42efd1f5c2a195f969b0fddc6cbb36476c0b8fff997b72374becefaf5c59cb1.png | simple | <table><tr><td>Independent variables</td><td>Unadjusted Rate Ratio (95 % CI)<sup>a</sup></td><td><i>P</i> value</td><td>Adjusted Rate Ratio (95 % CI)<sup>b</sup></td><td><i>P</i> value</td></tr><tr><td>Age at each pre-recruitment year (per year)</td><td>1.0 (1.0. 1.0)</td><td>0.048</td><td>1.0 (1.0, 1.0)</td><td>0.012<... | <table><tr><td>Independent variables</td><td>Unadjusted Rate Ratio (95 % CI)a</td><td>P value</td><td>Adjusted Rate Ratio (95 % CI)b</td><td>P value</td></tr><tr><td>Age at each pre-recruitment year (per year)</td><td>1.0 (1.0. 1.0)</td><td>0.048</td><td>1.0 (1.0, 1.0)</td><td>0.012</td></tr></table> | <table><tr><td>Time (per year)</td><td>1.2 (1.1. 1.2)</td><td><0.001</td><td>1.1 (1.0, 1.1)</td><td><0.001</td></tr><tr><td>Female gender</td><td>1.1 (0.9, 1.5)</td><td>0.349</td><td>1.0 (0.8, 1.2)</td><td>0.813</td></tr><tr><td>Aboriginals (yes vs. no)</td><td>0.9 (0.7, 1.3)</td><td>0.635</td><td>1.1 (0.8, 1.4)</td><t... |
44e3d14b7dfe551c2e91a47032655e772af37d9ab904d7c8e3988f9e978120a1.png | simple | <table><tr><td>Patients with:</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2 positive Criteria</td><td></td><td>Crit1+</td><td>Crit2+</td><td>Crit3+</td><td>Crit4+</td><td></td></tr><tr><td></td><td>Crit2+</td><td>11</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Crit3+</td><td>... | <table><tr><td>Patients with:</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2 positive Criteria</td><td></td><td>Crit1+</td><td>Crit2+</td><td>Crit3+</td><td>Crit4+</td><td></td></tr><tr><td></td><td>Crit2+</td><td>11</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Crit3+</td><td>... | <table><tr><td>Patients with:</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Crit5+</td><td>9</td><td>2</td><td>4</td><td>4</td><td></td></tr><tr><td>3 positive Criteria</td><td></td><td>Crit12+</td><td>Crit13+</td><td>Crit14+</td><td>Crit23+</td><td>Crit24+</td></tr><tr><td></td><td>Cr... |
a4ae770883c536a12879ad6bac064404d1b5e09eeb6e33240e117e1dc4c35309.png | simple | <table><tr><td>No.</td><td>Group</td><td>Treatment</td><td>Radiation<sup>a</sup></td><td>Microgravity</td></tr><tr><td>1</td><td>Spaceflight</td><td>Spaceflight static slot</td><td>1.92 mGy</td><td>μg</td></tr><tr><td>2</td><td>Spaceflight control</td><td>Spaceflight 1g-centrifuge slot</td><td>2.27 mGy</td><td>1g<... | <table><tr><td>No.</td><td>Group</td><td>Treatment</td><td>Radiationa</td><td>Microgravity</td></tr><tr><td>1</td><td>Spaceflight</td><td>Spaceflight static slot</td><td>1.92 mGy</td><td>μg</td></tr></table> | <table><tr><td>2</td><td>Spaceflight control</td><td>Spaceflight 1g-centrifuge slot</td><td>2.27 mGy</td><td>1g</td></tr><tr><td>3</td><td>Ground control</td><td>Ground static slot</td><td>–</td><td>1g</td></tr></table> |
cd1f5a2b88d315a0ebd6ae58d38461ffd11f10ed061b5bf7c62376b75ce4ee08.png | simple | <table><tr><td>Haplogroup</td><td>Gene vs Geography</td><td>p</td><td>Gene vs Language</td><td>p</td></tr><tr><td>R5</td><td>0.1276</td><td>0.0475</td><td>0.1748</td><td>0.2</td></tr><tr><td>R6</td><td>0.2654</td><td>0.037</td><td>0.13248</td><td>0.19</td></tr><tr><td>R7</td><td>0.299</td><td>0.023</td><td>0.219</td><t... | <table><tr><td>Haplogroup</td><td>Gene vs Geography</td><td>p</td><td>Gene vs Language</td><td>p</td></tr><tr><td>R5</td><td>0.1276</td><td>0.0475</td><td>0.1748</td><td>0.2</td></tr><tr><td>R6</td><td>0.2654</td><td>0.037</td><td>0.13248</td><td>0.19</td></tr></table> | <table><tr><td>Haplogroup</td><td>Gene vs Geography</td><td>p</td><td>Gene vs Language</td><td>p</td></tr><tr><td>R7</td><td>0.299</td><td>0.023</td><td>0.219</td><td>0.225</td></tr><tr><td>R8</td><td>0.211496</td><td>0.01753</td><td>0.23248</td><td>0.31</td></tr><tr><td>R30</td><td>0.189917</td><td>0.127</td><td>0.134... |
9e8c2baf82b32d805fe7858474744954e8e686f2af7b7084177e841e82361f17.png | complex | <table><tr><td>Characteristics</td><td>Variables</td><td>AMA (%)</td><td>STMA (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>27</td><td>26</td></tr><tr><td>Female</td><td>23</td><td>24</td></tr><tr><td rowspan="6">Marital status</td><td>Single (never married)</td><td>6.1</td><td>2.7</td></tr><tr><td>Marri... | <table><tr><td>Characteristics</td><td>Variables</td><td>AMA (%)</td><td>STMA (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>27</td><td>26</td></tr><tr><td>Female</td><td>23</td><td>24</td></tr><tr><td rowspan="6">Marital status</td><td>Single (never married)</td><td>6.1</td><td>2.7</td></tr><tr><td>Marri... | <table><tr><td>Characteristics</td><td>Variables</td><td>AMA (%)</td><td>STMA (%)</td></tr><tr><td>Age group</td><td>70+</td><td>6</td><td>8</td></tr><tr><td rowspan="8">Number of years living in the city (year group)</td><td>35–39</td><td>13.3</td><td>10.7</td></tr><tr><td>40–44</td><td>8</td><td>10</td></tr><tr><td>4... |
9e49a4fc88e3fe927254edf078c07094e1fee1adeccf29871a8957c013305904.png | complex | <table><tr><td></td><td colspan="4">Support Male Circumcision</td></tr><tr><td>Variables</td><td>Total (4, 874)</td><td>Yes (3,276)</td><td>No (1,598)</td><td><i>P</i>-values</td></tr><tr><td></td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td></td></tr><tr><td>Education</td><td></td><td></td><td></... | <table><tr><td></td><td colspan="4">Support Male Circumcision</td></tr><tr><td>Variables</td><td>Total (4, 874)</td><td>Yes (3,276)</td><td>No (1,598)</td><td>P-values</td></tr><tr><td></td><td>n (%)</td><td>n (%)</td><td>n (%)</td><td></td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td></tr><tr><td>No ... | <table><tr><td></td><td colspan="4">Support Male Circumcision</td></tr><tr><td>Variables</td><td>Total (4, 874)</td><td>Yes (3,276)</td><td>No (1,598)</td><td>P-values</td></tr><tr><td></td><td>n (%)</td><td>n (%)</td><td>n (%)</td><td></td></tr><tr><td>Richer</td><td>878 (18.0)</td><td>660 (75.2)</td><td>218 (24.8)</t... |
6060467036f7461e8507cb16e6194eb1527887bf60429837c2cf25fbf6de1275.png | complex | <table><tr><td>Pollutants</td><td>No. of other sites</td><td>Median correlation (range)</td></tr><tr><td colspan="2">Fine particles and components</td></tr><tr><td>24-hr avg PM<sub>2.5</sub></td><td>12<sup><i>b</i></sup></td><td>0.88 (0.46–0.95)</td></tr><tr><td>24-hr avg PM<sub>2.5</sub></td><td>3<sup><i>c</i></... | <table><tr><td>Pollutants</td><td>No. of other sites</td></tr><tr><td colspan="2">Fine particles and components</td></tr><tr><td>24-hr avg PM2.5</td><td>12b</td></tr><tr><td>24-hr avg PM2.5</td><td>3c</td></tr><tr><td>Major ions</td><td></td></tr><tr><td>24-hr avg SO42–</td><td>3</td></tr><tr><td>24-hr avg NO3–</td><td... | <table><tr><td>Median correlation (range)</td></tr><tr><td></td></tr><tr><td>0.88 (0.46–0.95)</td></tr><tr><td>0.88 (0.76–0.95)</td></tr><tr><td></td></tr><tr><td>0.90 (0.76–0.94)</td></tr><tr><td>0.88 (0.75–0.90)</td></tr><tr><td></td></tr><tr><td>0.43 (0.38–0.69)</td></tr><tr><td>0.47 (0.37–0.52)</td></tr><tr><td></t... |
606fe459ee9732f3df88c9922b12e0a7df688860458c894a6cefb1869f790349.png | simple | <table><tr><td></td><td>Tertiary hospitals (<i>n</i> = 50) Mean (SD) score</td><td>General hospitals (<i>n</i> = 109) Mean (SD) score</td></tr><tr><td>Reduction of rate of intubation and ventilation</td><td>4.5 (1.0)</td><td>4.8 (0.7)</td></tr><tr><td>Reduction in need for inter-hospital transfer</td><td>4.0 (1.2)</td>... | <table><tr><td></td><td>Tertiary</td><td>General hospitals (n = 109)</td></tr></table> | <table><tr><td></td><td> hospitals (n = 50) Mean (SD) score</td><td> Mean (SD) score</td></tr><tr><td>Reduction of rate of intubation and ventilation</td><td>4.5 (1.0)</td><td>4.8 (0.7)</td></tr><tr><td>Reduction in need for inter-hospital transfer</td><td>4.0 (1.2)</td><td>4.7 (0.7)</td></tr><tr><td>Reduction in lengt... |
fdfdd87746619c2c2d3f532707b46fbd2ef6f5ac2d016fd1a669c1a31559da5e.png | complex | <table><tr><td>Measurement year</td><td>2008</td><td>2010</td><td>2013</td></tr><tr><td>Participation</td><td></td><td></td><td></td></tr><tr><td>All measured children (n, % of eligible)</td><td>1142 (86)</td><td>1448 (85)</td><td>1868 (91)</td></tr><tr><td><i>Girls/boys (% of eligible)</i></td><td>85/86</td><td>84/85<... | <table><tr><td>Measurement year</td><td>2008</td><td>2010</td><td>2013</td></tr><tr><td>Participation</td><td></td><td></td><td></td></tr><tr><td>All measured children (n, % of eligible)</td><td>1142 (86)</td><td>1448 (85)</td><td>1868 (91)</td></tr><tr><td>Girls/boys (% of eligible)</td><td>85/86</td><td>84/85</td><td... | <table><tr><td>Completed FQ (n, % of measured)</td><td>833 (73)</td><td>1085 (75)</td><td>1134 (61)</td></tr><tr><td>Girls/boys (% of measured)</td><td>76/70</td><td>76/74</td><td>61/61</td></tr><tr><td>Distribution of children according to individual socioeconomic characteristics from FQ</td><td></td><td></td><td></td... |
18b1792afc327080e3feac9dbac06415e6322fbc535b62f4d6c082c017e3afd1.png | simple | <table><tr><td>Importance of the Water Supply Issue to the Household</td><td>Percentage</td></tr><tr><td>Absolutely not important</td><td>10</td></tr><tr><td>Not important</td><td>10</td></tr><tr><td>Between important and not important</td><td>8</td></tr><tr><td>Important</td><td>38</td></tr><tr><td>Very important</td>... | <table><tr><td>Importance of the Water Supply Issue to the Household</td><td>Percentage</td></tr><tr><td>Absolutely not important</td><td>10</td></tr><tr><td>Not important</td><td>10</td></tr><tr><td>Between important and not important</td><td>8</td></tr><tr><td>I</td><td>38</td></tr></table> | <table><tr><td>Importance of the Water Supply Issue to the Household</td><td>Percentage</td></tr><tr><td>mportant</td><td></td></tr><tr><td>Very important</td><td>34</td></tr></table> |
8daf526cee422bb7f1e3306bbcac7f5ecbcd9fa24e6d171a8d084686a87836d8.png | complex | <table><tr><td rowspan="2">Time</td><td rowspan="2">Side Swing (°)</td><td rowspan="2">Regions</td><td rowspan="2">Positioning Accuracy</td><td colspan="2">Average Offset</td><td colspan="2">Relative Accuracy</td></tr><tr><td>dx</td><td>dy</td><td>mx</td><td>my</td></tr><tr><td>27 December 2014 15:27</td><td>ͨ... | <table><tr><td rowspan="2">Time</td><td rowspan="2">Side Swing (°)</td></tr><tr></tr><tr><td>27 December 2014 15:27</td><td>−3.820</td></tr><tr><td>9 February 2015 11:10</td><td>−5.532</td></tr><tr><td>16 March 2015 13:20</td><td>4.152</td></tr><tr><td>1 May 2015 16:13</td><td>3.318</td></tr><tr><td>23 July 2015 15:27<... | <table><tr><td rowspan="2">Regions</td><td rowspan="2">Positioning Accuracy</td><td colspan="2">Average Offset</td><td colspan="2">Relative Accuracy</td></tr><tr><td>dx</td><td>dy</td><td>mx</td><td>my</td></tr><tr><td>Yili</td><td>13.141</td><td>−11.581</td><td>−6.212</td><td>1.665</td><td>1.721</td></tr><tr><td>Anyan... |
f2153633164c28f93c9eb548f2b361e0cbdef26de249c43b8abc135a9efd70a5.png | complex | <table><tr><td></td><td>Type 1 diabetes n = 199</td><td>All controls n = 178</td><td>p value</td></tr><tr><td>Sex (male:female)</td><td>98:101</td><td>84:94</td><td>0.69</td></tr><tr><td>Age (years)</td><td>14.4 ± 1.6</td><td>14.4 ± 2.1</td><td>0.80</td></tr><tr><td>Height (cm)</td><td>163 ± 10</td><td>1... | <table><tr><td></td><td>Type 1 diabetes n = 199</td><td>All controls n = 178</td><td>p value</td></tr><tr><td>Sex (male:female)</td><td>98:101</td><td>84:94</td><td>0.69</td></tr><tr><td>Age (years)</td><td>14.4 ± 1.6</td><td>14.4 ± 2.1</td><td>0.80</td></tr><tr><td>Height (cm)</td><td>163 ± 10</td><td>162 ± 11</td><td... | <table><tr><td></td><td>Type 1 diabetes n = 199</td><td>All controls n = 178</td><td>p value</td></tr><tr><td>ump</td><td>.8</td><td>–</td><td></td></tr><tr><td>Multiple injections</td><td>30.2</td><td>–</td><td></td></tr><tr><td colspan="4">Smoking status n (%)</td></tr><tr><td>Never smoked</td><td>181 (92.8)</td><td>... |
44845694700af06012dfdb2ee8097112f6cb7fd756e5a0225d1dc25ddf38bff9.png | simple | <table><tr><td></td><td>UK samples positive/total (%)</td><td>Nigerian samples positive/total (%)</td><td>p value</td></tr><tr><td>Molecular markers</td><td></td><td></td><td></td></tr><tr><td>ER</td><td>20/34 (58.8)</td><td>9/34 (26.5)</td><td>p = 0.0142</td></tr><tr><td>PR</td><td>18/34 (52.9)</td><td>10/34 (29.4)</t... | <table><tr><td></td><td>UK samples positive/total (%)</td><td>Nigerian samples positive/total (%)</td><td>p value</td></tr><tr><td>Molecular markers</td><td></td><td></td><td></td></tr><tr><td>ER</td><td>20/34 (58.8)</td><td>9/34 (26.5)</td><td>p = 0.0142</td></tr><tr><td>PR</td><td>18/34 (52.9)</td><td>10/34 (29.4)</t... | <table><tr><td>Histological Grade</td><td></td><td></td><td></td></tr><tr><td>Grade 1</td><td>1/34 (2.9)</td><td>2/34 (5)</td><td>p = 1 (Fisher’s exact)</td></tr><tr><td>Grade 2</td><td>12/34 (35.3)</td><td>8/34 (23.5)</td><td>p = 0.4246</td></tr><tr><td>Grade 3</td><td>21/34 (61.8)</td><td>24/34 (70.6)</td><td>p = 0.6... |
909714223ec7c9a6688d04e5f0584142bcadf6d8900c12f3b840ae3c289b8abe.png | simple | <table><tr><td>Healthcare professional</td><td>Gender</td><td>Description of Role</td></tr><tr><td>Respiratory Physician</td><td>Female</td><td>Assessment of COPD and comorbidities, preparation and review of COPD treatment plans</td></tr><tr><td>Registered Clinic Nurse</td><td>Female</td><td>Support assessments, admini... | <table><tr><td>Healthcare professional</td><td>Gender</td><td>Description of Role</td></tr><tr><td>Respiratory Physician</td><td>Female</td><td>Assessment of COPD and comorbidities, preparation and review of COPD treatment plans</td></tr><tr><td>Registered Clinic Nurse</td><td>Female</td><td>Support assessments, admini... | <table><tr><td>General Practitioner</td><td>Male</td><td>Prepare health care plan, receive and integrate test results in between study visits, provide referrals to specialists, allied health and Respiratory HEAL</td></tr></table> |
a6d03a20be2dfff1d9a42998098f9ff27032d25f3707ba2ebad2cebaa9df33a9.png | simple | <table><tr><td></td><td>Relative Risk</td><td>95% Confidence Interval</td><td>P-value</td></tr><tr><td>Gleason 7 vs. 6</td><td>1.37</td><td>1.19, 1.56</td><td><0.0001</td></tr><tr><td>Gleason 8 to10 vs. 6</td><td>1.56</td><td>1.37, 1.78</td><td><0.0001</td></tr><tr><td>Gleason 8 to10 vs. 7</td><td>1.14</td><td>1.... | <table><tr><td></td><td>Relative Risk</td><td>95% Confidence Interval</td><td>P-value</td></tr><tr><td>Gleason 7 vs. 6</td><td>1.37</td><td>1.19, 1.56</td><td><0.0001</td></tr><tr><td>Gleason 8 to10 vs. 6</td><td>1.56</td><td>1.37, 1.78</td><td><0.0001</td></tr><tr><td>Gleason 8 to10 vs. 7</td><td>1.14</td><td>1.04, 1.... | <table><tr><td>Specialty:</td><td></td><td></td><td></td></tr><tr><td>Radiation oncology vs. Urology</td><td>1.26</td><td>1.15, 1.38</td><td><0.0001</td></tr></table> |
a32cc9cab6282d522df38705250d4430b454c96e84954a21a468de10783b7652.png | complex | <table><tr><td>Group</td><td colspan="2">≤35 years old</td><td colspan="2">36-38 years old</td><td colspan="2">39-40 years old</td><td colspan="2">>40 years old</td></tr><tr><td>Variable</td><td>RC</td><td><i>p</i></td><td>RC</td><td><i>p</i></td><td>RC</td><td><i>p</i></td><td>RC</td><td><i>p</i></td></tr><tr... | <table><tr><td>Group</td><td colspan="2">≤35 years old</td><td colspan="2">36-38 years old</td><td colspan="2">39-40 years old</td><td colspan="2">>40 years old</td></tr></table> | <table><tr><td>Variable</td><td>RC</td><td>p</td><td>RC</td><td>p</td><td>RC</td><td>p</td><td>RC</td><td>p</td></tr><tr><td colspan="9">Laboratory outcomes</td></tr><tr><td>Fertilization rate</td><td>-0.001</td><td>NS</td><td>0.000</td><td>NS</td><td>0.001</td><td>NS</td><td>-0.002</td><td>NS</td></tr><tr><td>High qua... |
dbc3ce6045bcc1f19a7e136e963159c84938eba49c99377dbe87715f65835d31.png | simple | <table><tr><td> </td><td>All N = 15</td><td>18 years or younger N = 25</td><td>Over 18 Years N = 18</td></tr><tr><td>Medication class</td><td>Number prescribed this medication</td><td>Number prescribed this medication</td><td>Number prescribed this medication</td></tr><tr><td>Citalopram</td><td>5 (9.1%)</td><td>2 (8.0%... | <table><tr><td></td><td>All N = 15</td><td>18 years or younger N = 25</td><td>Over 18 Years N = 18</td></tr><tr><td>Medicati</td><td>Number prescr</td><td>Number</td><td>Number prescribed this medic</td></tr></table> | <table><tr><td>on class</td><td>ibed this medication</td><td> prescribed this medication</td><td>ation</td></tr><tr><td>Citalopram</td><td>5 (9.1%)</td><td>2 (8.0%)</td><td>3 (10.0%)</td></tr><tr><td>Escitalopram</td><td>3 (5.5%)</td><td>0 (0.0%)</td><td>3 (10.0%)</td></tr><tr><td>Fluoxetine</td><td>39 (70.9%)</td><td>... |
76eff35b7e02a323944cad15d66da4b3efb5deb2e9c08886572f5e4ad5da62ee.png | simple | <table><tr><td>Dependent variable</td><td>Independent variables</td><td>Odds ratio</td><td>CI (95%)</td><td><i>P</i> value</td></tr><tr><td></td><td>Adiponectin</td><td>0.7</td><td>0.33–1.07</td><td>0.06</td></tr><tr><td></td><td>Age</td><td>0.9</td><td>0.8–1.1</td><td>0.9</td></tr><tr><td> PCOS</td><td>WC<... | <table><tr><td>Dependent variable</td><td>Independent variables</td><td>Odds ratio</td><td>CI (95%)</td><td>P value</td></tr><tr><td></td><td>Adiponectin</td><td>0.7</td><td>0.33–1.07</td><td>0.06</td></tr><tr><td></td><td>Age</td><td>0.9</td><td>0.8–1.1</td><td>0.9</td></tr><tr><td>PCOS</td><td>WC</td><td>0.86</td><td... | <table><tr><td>Dependent variable</td><td>Independent variables</td><td>Odds ratio</td><td>CI (95%)</td><td>P value</td></tr><tr><td></td><td>25OHD</td><td>1.9</td><td>1.3–2.5</td><td>0.002</td></tr></table> |
444bd9cb6bc41048b28dd89cf9e5c79ed690b6662fa9df03f689d09cd7965e6b.png | simple | <table><tr><td>Feature</td><td>Control</td><td>Treatment</td><td><i>p</i></td></tr><tr><td>Fat necrosis*</td><td>2.8±0.3</td><td>2.8±0.5</td><td>0.791</td></tr><tr><td>Inflammatory infiltrate*</td><td>3.6±0.1</td><td>3.4±0.2</td><td>0.247</td></tr><tr><td>Interstitial Edema**</td><td>4.0 (3.5-4.0)</... | <table><tr><td>Feature</td><td>Control</td><td>Treatment</td><td>p</td></tr><tr><td>Fat necrosis*</td><td>2.8±0.3</td><td>2.8±0.5</td><td>0.791</td></tr><tr><td>Inflammatory infiltrate*</td><td>3.6±0.1</td><td>3.4±0.2</td><td>0.247</td></tr><tr><td>Interstitial Edema**</td><td>4.0 (3.5-4.0)</td><td>3.5 (3.5-3.8)</td><t... | <table><tr><td>Hemorrhagic foci**</td><td>4.0 (2.6-4.0)</td><td>3.5 (3.0-3.8)</td><td>0.622</td></tr></table> |
566cf0d1e29275e83184c1f49282995dad0101c86d88f9229c42032b5a739e31.png | simple | <table><tr><td>Age (mean ± SD) years</td><td>64.3 (± 3.5)</td></tr><tr><td>Gender male/female</td><td>12/8</td></tr><tr><td>Pre-op logMAR VA (mean ± SD)</td><td>1.15 ± 0.88</td></tr><tr><td>Post-op logMAR VA (mean ± SD)</td><td>0.55 ± 0.30</td></tr><tr><td>Lens statusPhakic/IOL</td><td>4/1... | <table><tr><td>Age (mean ± SD) years</td></tr><tr><td>Gender male/female</td></tr><tr><td>Pre-op logMAR VA (mean ± SD)</td></tr><tr><td>Post-op logMAR VA (mean ± SD)</td></tr><tr><td>Lens statusPhakic/IOL</td></tr><tr><td>Duration of detachment (mean ± SD) days</td></tr><tr><td>Quadrants detached</td></tr><tr><td>Locat... | <table><tr><td>64.3 (± 3.5)</td></tr><tr><td>12/8</td></tr><tr><td>1.15 ± 0.88</td></tr><tr><td>0.55 ± 0.30</td></tr><tr><td>4/16</td></tr><tr><td>6.25 ± 3.44</td></tr><tr><td>2.95 (± 0.75)</td></tr><tr><td>16/4</td></tr><tr><td>11.7 ± 2.6</td></tr><tr><td>18.9 ± 4.9</td></tr><tr><td>16.8 ± 4.7</td></tr></table> |
f33515e95dd643e8eda02d48b1460bc6847dc5527d9f15e5b1582eae72e007f4.png | simple | <table><tr><td></td><td>Picture name</td><td>Related distractor</td><td>Unrelated distractor</td></tr><tr><td>Animals</td><td>Hert (deer)</td><td>Konijn</td><td>Piano</td></tr><tr><td></td><td>Konijn (rabbit)</td><td>Hert</td><td>Drumstel</td></tr><tr><td></td><td>Zwaan (swan)</td><td>Geit</td><td>Bus</td></tr><tr><td>... | <table><tr><td></td><td>Picture name</td><td>Related distractor</td><td>Unrelated distractor</td></tr><tr><td>Animals</td><td>Hert (deer)</td><td>Konijn</td><td>Piano</td></tr><tr><td></td><td>Konijn (rabbit)</td><td>Hert</td><td>Drumstel</td></tr><tr><td></td><td>Zwaan (swan)</td><td>Geit</td><td>Bus</td></tr><tr><td>... | <table><tr><td></td><td>Picture name</td><td>Related distractor</td><td>Unrelated distractor</td></tr><tr><td></td><td>Peer (pear)</td><td>Appel</td><td>Hemd</td></tr><tr><td>Music instruments</td><td>Drumstel (drums)</td><td>Gitaar</td><td>Bureau</td></tr><tr><td></td><td>Gitaar (guitar)</td><td>Drumstel</td><td>Jas</... |
4b9a3307499d08b306d89039f891a451a6eb69a59eb488924d1ba89f1e995caa.png | complex | <table><tr><td>Secondary disability</td><td>Selection</td></tr><tr><td>Difficulties managing daily life</td><td>Societal support<sup>a</sup> in terms of different forms of housing conditions</td></tr><tr><td>Problems at school</td><td>Special education (school for children with intellectual development disorders, prima... | <table><tr><td>Secondary disability</td><td>Selection</td></tr><tr><td>Difficulties managing daily life</td><td>Societal supporta in terms of different forms of housing conditions</td></tr><tr><td>Problems at school</td><td>Special education (school for children with intellectual development disorders, primary school l... | <table><tr><td>Secondary disability</td><td>Selection</td></tr><tr><td rowspan="2">Suicidal ideation</td><td>No separate calculation</td></tr><tr><td>Included in other cost references</td></tr><tr><td rowspan="2">Criminality</td><td>No separate calculation</td></tr><tr><td>Cost included in alcohol/drug abuse</td></tr><... |
e488b64fb064431a304170f06c2c3531aafdf30b444861111798ba905ae2a45d.png | simple | <table><tr><td>Variable</td><td>FLEEOX (n=99) (%)</td><td>XELOX (n=99) (%)</td><td><i>P</i></td></tr><tr><td>Response to NAC</td><td></td><td></td><td>0.026</td></tr><tr><td> CR</td><td>13 (13.1)</td><td>3 (3.0)</td><td></td></tr><tr><td> PR</td><td>67 (67.7)</td><td>65 (65.7)</td><td></td></tr><tr><td> SD</td><td>9 (9... | <table><tr><td>Variable</td><td>FLEEOX (n=99) (%)</td><td>XELOX (n=99) (%)</td><td>P</td></tr><tr><td>Response to NAC</td><td></td><td></td><td>0.026</td></tr><tr><td>CR</td><td>13 (13.1)</td><td>3 (3.0)</td><td></td></tr><tr><td>PR</td><td>67 (67.7)</td><td>65 (65.7)</td><td></td></tr><tr><td>SD</td><td>9 (9.1)</td><t... | <table><tr><td>RR (CR plus PR)</td><td>80 (80.8)</td><td>68 (68.7)</td><td>0.018</td></tr><tr><td>DCR (CR plus PR plus SD)</td><td>89 (89.9)</td><td>84 (84.8)</td><td>0.196</td></tr></table> |
81328528433caae1f681e3544b9f2a96a9a565cc64e2631ab8b9dbd3a338636d.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>Altitude <1500 m</td><td>Altitude >1500 m</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td><i>n</i> = 26,896</td><td><i>n</i> = 3978</td></tr><tr><td>COPD prevalence (%)</td><td>9.9</td><td>8.5</td><td><0.005</td></tr><tr><td>Mean FEV<sub>1</sub> (Litre, SD... | <table><tr><td rowspan="2">Characteristic</td><td>Altitude <1500 m</td><td>Altitude >1500 m</td><td rowspan="2">p-val</td></tr><tr><td>n = 2</td><td>n = 397</td></tr></table> | <table><tr><td>s</td><td>6,896</td><td>8</td><td>ue</td></tr><tr><td>COPD prevalence (%)</td><td>9.9</td><td>8.5</td><td><0.005</td></tr><tr><td>Mean FEV1 (Litre, SD)</td><td>2.66 (0,85)</td><td>2.45 (0.78)</td><td>0.010</td></tr><tr><td>Mean FVC (Litre, SD)</td><td>3.47 (1.05)</td><td>3.20 (0.90)</td><td><0.001</td></... |
3831be9a5acaa234b9f172f3da2c17b5fe9529602845136d9c4274722d58de32.png | simple | <table><tr><td>Animal yields</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Milk, Eggs</td><td>Easily measurable, almost complete edible</td><td>Variation in protein, fat and energy yield, analyses may be useful</td></tr><tr><td>Body weight gain</td><td>Easily measurable</td><td>High portion of non edible fr... | <table><tr><td>Animal yields</td></tr><tr><td>Milk, Eggs</td></tr><tr><td>Body weight gain</td></tr><tr><td>Carcass weight</td></tr><tr><td>Meat, edible fraction</td></tr><tr><td>Edible protein</td></tr></table> | <table><tr><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Easily measurable, almost complete edible</td><td>Variation in protein, fat and energy yield, analyses may be useful</td></tr><tr><td>Easily measurable</td><td>High portion of non edible fractions in the gains</td></tr><tr><td>Easily measurable</td><td>Co... |
8008a7a6bddb39215bde685c8405fc6b32c77fdc63c46749a5399d10bafaf471.png | simple | <table><tr><td></td><td>Number (%)</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Patient characteristics</td></tr><tr><td>Age (year)</td><td>52</td><td>44.8 ± 14</td><td>22–78</td></tr><tr><td>Gender</td></tr><tr><td> Male</td><td>34</td><td></td><td></td></tr><tr><td> Female</td><td>18</td><td></td>... | <table><tr><td></td><td>Number (%)</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Patient characteristics</td><td colspan="3"></td></tr><tr><td>Age (year)</td><td>52</td><td>44.8 ± 14</td><td>22–78</td></tr><tr><td>Gender</td><td colspan="3"></td></tr><tr><td>Male</td><td>34</td><td></td><td></td></tr><tr><td>Female<... | <table><tr><td></td><td>Number (%)</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Neurological function (RTOG)</td><td>52</td><td>1.19 ± 1.15</td><td>0–3</td></tr><tr><td>No neurological symptoms</td><td>17 (32.7%)</td><td></td><td></td></tr><tr><td>Minor neurological symptoms</td><td>21 (40.4%)</td><td></td><td rows... |
2920bc2ebe5ce728a65288c0b6c5e083e48a3b51d01228c35c8801e4ad708d2f.png | simple | <table><tr><td>Symptoms</td><td>Frequency</td><td>Number</td><td>Percentage</td></tr><tr><td>Sneezing</td><td>No symptoms</td><td>1076</td><td>69.70%</td></tr><tr><td></td><td>Occasional</td><td>398</td><td>25.80%</td></tr><tr><td></td><td>Frequent</td><td>69</td><td>4.50%</td></tr><tr><td>Cough</td><td>No symptoms</td... | <table><tr><td>Symptoms</td><td>Frequency</td><td>Number</td><td>Percentage</td></tr></table> | <table><tr><td>Sneezing</td><td>No symptoms</td><td>1076</td><td>69.70%</td></tr><tr><td></td><td>Occasional</td><td>398</td><td>25.80%</td></tr><tr><td></td><td>Frequent</td><td>69</td><td>4.50%</td></tr><tr><td>Cough</td><td>No symptoms</td><td>1380</td><td>89.40%</td></tr><tr><td></td><td>Occasional</td><td>149</td>... |
dc1156be60b705a9ab6ae633fd43f0ef9ad77dc42d35d51eb2e4ff9ba1c81604.png | complex | <table><tr><td rowspan="2">Compound</td><td>Concentration</td><td>Relative activity</td></tr><tr><td>(mM)</td><td>(%)</td></tr><tr><td>dl-<i>threo</i>-<i>β</i>-phenylserine</td><td>20</td><td>100</td></tr><tr><td>d-<i>threo</i>-<i>β</i>-phenylserine</td><td>10</td><td>0</td></tr><tr><td>dl-<i>erythro</i>-<i>&... | <table><tr><td rowspan="2">Compound</td><td>Concentration</td><td>Relative activity</td></tr><tr><td>(mM)</td><td>(%)</td></tr><tr><td>dl-threo-β-phenylserine</td><td>20</td><td>100</td></tr><tr><td>d-threo-β-phenylserine</td><td>10</td><td>0</td></tr><tr><td>dl-erythro-β-phenylserine</td><td>20</td><td>840</td></tr></... | <table><tr><td rowspan="2">Compound</td><td>Concentration</td><td>Relative activity</td></tr><tr><td>(mM)</td><td>(%)</td></tr><tr><td>dl-threo-(2-thienyl)serine</td><td>20</td><td>530</td></tr><tr><td>(S)-phenylethanol</td><td>10</td><td>6.9</td></tr><tr><td>dl-hydroxynorvaline</td><td>20</td><td>0</td></tr><tr><td>l-... |
20b11501197a133e660c0ac9a2ddac7ce2d1d41df21324a2fc9ea99947c1c7d8.png | complex | <table><tr><td></td><td colspan="2">Controls</td><td colspan="2">Earthquake victims</td></tr><tr><td>Measures</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>ISI</td><td>5.05</td><td>3.5</td><td>6.35</td><td>4</td></tr><tr><td>IUS-12</td><td>35.00</td><td>15.2</td><td>42.54</td><td>16.7</td></tr><tr><t... | <table><tr><td></td><td colspan="2">Controls</td><td colspan="2">Earthquake victims</td></tr><tr><td>Measures</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>ISI</td><td>5.05</td><td>3.5</td><td>6.35</td><td>4</td></tr><tr><td>IUS-12</td><td>35.00</td><td>15.2</td><td>42.54</td><td>16.7</td></tr><tr><t... | <table><tr><td></td><td colspan="2">Controls</td><td colspan="2">Earthquake victims</td></tr><tr><td>Measures</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>BDI</td><td>6.54</td><td>5.2</td><td>8.56</td><td>5.8</td></tr><tr><td>ASI-3 total score*</td><td>10.90</td><td>8.3</td><td>18.21</td><td>13.3</t... |
ca21d22cafe35b9e6b76bc3dfad32ba3b4c06d477db3b53cec5426ccf9309671.png | simple | <table><tr><td></td><td>No (%)</td><td>OR</td><td>Yes (%)</td><td>OR (95% CI)</td><td><i>P</i></td></tr><tr><td>High TG</td><td>10.6</td><td>1</td><td>23.3</td><td>1.4 (1.0–2.0)</td><td> 0.0334</td></tr><tr><td>Low HDL-C</td><td>11.0</td><td>1</td><td>12.6</td><td>0.9 (0.6–1.2)</td><td> 0.4507</td></tr><tr>... | <table><tr><td></td><td>No (%)</td><td>OR</td><td>Yes (%)</td><td>OR (95% CI)</td><td>P</td></tr></table> | <table><tr><td>High TG</td><td>10.6</td><td>1</td><td>23.3</td><td>1.4 (1.0–2.0)</td><td>0.0334</td></tr><tr><td>Low HDL-C</td><td>11.0</td><td>1</td><td>12.6</td><td>0.9 (0.6–1.2)</td><td>0.4507</td></tr><tr><td>Hyperglycemia</td><td>11.0</td><td>1</td><td>15.5</td><td>1.5 (0.9–2.5)</td><td>0.0890</td></tr><tr><td>Met... |
a140caf76f612107390af42ffcc993777da7bf31b3f6fb54011099769c82209d.png | simple | <table><tr><td></td><td>Left thalamic infarct patients (<i>n</i> = 12)</td><td>Healthy control participants (<i>n</i> = 25)</td><td><i>P</i> value</td><td>dMTT subgroup (<i>n</i> = 7)</td><td>iMTT subgroup (<i>n</i> = 5)</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>53.2 (14.6) [25, 75]</td><td>52.6 (11.6... | <table><tr><td></td><td>Left thalamic infarct patients (n = 12)</td><td>Healthy control participants (n = 25)</td><td>P value</td><td>dMTT subgroup (n = 7)</td><td>iMTT subgroup (n = 5)</td><td>P value</td></tr><tr><td>Age (years)</td><td>53.2 (14.6) [25, 75]</td><td>52.6 (11.6) [25, 69]</td><td>0.86</td><td>58.9 (16.6... | <table><tr><td>Handedness (right (R)/left (L)/ambidextrous (A))</td><td>11 R/1A</td><td>22R/3L</td><td>0.17</td><td>6 R/1A</td><td>5 R</td><td>0.38</td></tr><tr><td>Time since onset</td><td>589 (588.9) days [3 months, 4 years 11 months]</td><td>–</td><td>–</td><td>527 (647.2) days [3 months, 4 years 11 months]</td><td>... |
c9ae4665cbcf57638649ec5ef884d67822a31032e9ea117164ebcc57c74d5f3d.png | simple | <table><tr><td>Clinical Training Programs in</td><td>Nation</td><td>Commenced</td></tr><tr><td>ROMP </td><td>ThailandThe Philippines Malaysia </td><td>2007 (completed) 20092011</td></tr><tr><td>DRMP </td><td>The Philippines Thailand </td><td>20102010</td></tr><tr><td>NMP </td><td>BangladeshThailand</td><td>20102011 </t... | <table><tr><td>Clinical Training Programs in</td></tr><tr><td>ROMP</td></tr><tr><td>DRMP</td></tr><tr><td>NMP</td></tr></table> | <table><tr><td>Nation</td><td>Commenced</td></tr><tr><td>ThailandThe Philippines Malaysia</td><td>2007 (completed) 20092011</td></tr><tr><td>The Philippines Thailand</td><td>20102010</td></tr><tr><td>BangladeshThailand</td><td>20102011</td></tr></table> |
3416b363120ed9b1c575aaa60e28bacbd01bbbc7e75137f582f73d975baf9849.png | complex | <table><tr><td colspan="2">Absolute power density (mean ± SE, μV<sup>2</sup>)</td><td colspan="2">Relative power density<sup>a </sup>(mean ± SE, %)</td></tr><tr><td>Eyes closed</td><td>Eyes open</td><td>Eyes closed</td><td>Eyes open</td></tr><tr><td>23.9 ± 3.5*</td><td>2.4 ± 0.2</td><td>60.8 &#... | <table><tr><td colspan="2">Absolute power density (mean ± SE, μV2)</td><td colspan="2">Relative power densitya (mean ± SE, %)</td></tr></table> | <table><tr><td>Eyes closed</td><td>Eyes open</td><td>Eyes closed</td><td>Eyes open</td></tr><tr><td>23.9 ± 3.5*</td><td>2.4 ± 0.2</td><td>60.8 ± 2.4*</td><td>26.0 ± 1.7</td></tr></table> |
c0e987a58fcca7696ec838f87cc0bff05354fabdd65d0903b8739056e3a65956.png | complex | <table><tr><td colspan="2">Number of families<sup><i>b</i></sup></td><td>46</td></tr><tr><td rowspan="5">Number of children < 12<sup><i>b</i></sup></td><td>Age (years)</td><td> </td></tr><tr><td><i>0–3</i></td><td>28</td></tr><tr><td><i>3–6</i></td><td>27</td></tr><tr><td><i>6–12</i></td><td>23</td... | <table><tr><td colspan="2">Number of familiesb</td><td>46</td></tr><tr><td rowspan="5">Number of children < 12b</td><td>Age (years)</td><td></td></tr><tr><td>0–3</td><td>28</td></tr><tr><td>3–6</td><td>27</td></tr><tr><td>6–12</td><td>23</td></tr><tr><td>Total</td><td>78</td></tr><tr><td rowspan="3">Number of children ... | <table><tr><td>Number of children attending Mobile Crèches centerb</td><td>Total</td><td>76</td></tr><tr><td colspan="2">Average duration of attendance at Mobile Crèches center (child-days per child)c</td><td>48</td></tr></table> |
a2edb1880adde3fb543da054c3eb586fad44d80cd12e33a655bae24dc17cca00.png | simple | <table><tr><td>History</td><td>• Activity and employment status</td></tr><tr><td></td><td>• Description of LBP</td></tr><tr><td></td><td>• Response to previous treatment</td></tr><tr><td></td><td>• Co-morbidities and medications</td></tr><tr><td>Examination</td><td>• Vitals (height, weight... | <table><tr><td>History</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Examination</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Imaging</td></tr><tr><td></td></tr><tr><td>Biomechanical Assessment</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Psychosocial Assessmen... | <table><tr><td>• Activity and employment status</td></tr><tr><td>• Description of LBP</td></tr><tr><td>• Response to previous treatment</td></tr><tr><td>• Co-morbidities and medications</td></tr><tr><td>• Vitals (height, weight, blood pressure)</td></tr><tr><td>• Orthopedic exam (Lasegue, Patrick Fabre, Kemp, Gaenslen,... |
d31fed9c5b25e4529d14b57372633919cec8e5344ee476f9f6a31903aa95c192.png | complex | <table><tr><td></td><td colspan="4">WILD TYPE</td><td colspan="4">ADIPONECTIN-/-</td></tr><tr><td></td><td colspan="2">SHAM</td><td colspan="2">TAC</td><td colspan="2">SHAM</td><td colspan="2">TAC</td></tr><tr><td></td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td... | <table><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Serum Adiponectin (μg·ml-1)</td></tr><tr><td>Serum HMW Adiponectin (μg·ml-1)</td></tr><tr><td>Adiponectin mRNA in Epididymal Fat</td></tr><tr><td>PDK4 mRNA in LV</td></tr><tr><td>UCP3 mRNA in LV</td></tr><tr><td>Serum Glucose (mM)</td></tr><tr><td>Ser... | <table><tr><td colspan="4">WILD TYPE</td><td colspan="4">ADIPONECTIN-/-</td></tr><tr><td colspan="2">SHAM</td><td colspan="2">TAC</td><td colspan="2">SHAM</td><td colspan="2">TAC</td></tr><tr><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td></tr><tr><td... |
e9b6f4a231310291b27e86c22bf773aba0d8179650f22046a08aa7083eb816cb.png | complex | <table><tr><td colspan="2"></td><td colspan="3">HAQ-P<sup>b</sup></td><td></td><td colspan="3">HAQ-T<sup>c</sup></td></tr><tr><td></td><td></td><td><i>Relation to the therapist</i></td><td><i>Satisfaction with therapeutic outcome</i></td><td><i>Helping alliance</i></td><td></td><td><i>Relation to the patient</i></td><t... | <table><tr><td colspan="2"></td><td colspan="3">HAQ-Pb</td><td></td><td colspan="3">HAQ-Tc</td></tr><tr><td></td><td></td><td>Relation to the therapist</td><td>Satisfaction with therapeutic outcome</td><td>Helping alliance</td><td></td><td>Relation to the patient</td><td>Satisfaction with therapeutic outcome</td><td>He... | <table><tr><td colspan="2"></td><td colspan="3">HAQ-Pb</td><td></td><td colspan="3">HAQ-Tc</td></tr><tr><td>Non-assertive</td><td>20.04 (6.68)</td><td>−0.03</td><td>−0.12</td><td>− 0.08</td><td></td><td>0.00</td><td>0.01</td><td>0.01</td></tr><tr><td>Overly accommodating</td><td>17.49 (5.83)</td><td>0.07</td><td>−0.00<... |
e1a9141746cb288895915dd6acc419644b97479eac559b3fc2d69b90dfae94bf.png | complex | <table><tr><td></td><td>Study population</td><td colspan="2">Respondents</td><td colspan="2">Respondents having consultations concerning sickness certification at least a few times a year</td></tr><tr><td></td><td>n</td><td>n</td><td>% of study population</td><td>n</td><td>% of the respondents</td></tr><tr><td>All</td>... | <table><tr><td></td><td>Study population</td><td colspan="2">Respondents</td><td colspan="2">Respondents having consultations concerning sickness certification at least a few times a year</td></tr><tr><td></td><td>n</td><td>n</td><td>% of study population</td><td>n</td><td>% of the respondents</td></tr><tr><td>All</td>... | <table><tr><td></td><td>Study population</td><td colspan="2">Respondents</td><td colspan="2">Respondents having consultations concerning sickness certification at least a few times a year</td></tr><tr><td></td><td>n</td><td>n</td><td>% of study population</td><td>n</td><td>% of the respondents</td></tr><tr><td>Stockhol... |
c90b7af4dc812c097f069676dc73d0e23127323f91e9e908b2ed419d4b76fdb9.png | simple | <table><tr><td>Symptoms (Discomforts)</td><td>after 1 ED</td><td>after 2 ED</td><td>after 3 ED</td><td><i>n</i></td></tr><tr><td>headache</td><td>3 (8%)</td><td>7 (19%)</td><td>3 (8%)</td><td>13</td></tr><tr><td>light chest pain</td><td>-</td><td>-</td><td>2 (5%)</td><td>2</td></tr><tr><td>stomachache</td><td>-</td><td... | <table><tr><td>Symptoms (Discomforts)</td></tr><tr><td>headache</td></tr><tr><td>light chest pain</td></tr><tr><td>stomachache</td></tr><tr><td>excitation</td></tr><tr><td>anxiety</td></tr><tr><td>shaking hands</td></tr><tr><td>somnolence</td></tr><tr><td>malaise and others</td></tr></table> | <table><tr><td>after 1 ED</td><td>after 2 ED</td><td>after 3 ED</td><td>n</td></tr><tr><td>3 (8%)</td><td>7 (19%)</td><td>3 (8%)</td><td>13</td></tr><tr><td>-</td><td>-</td><td>2 (5%)</td><td>2</td></tr><tr><td>-</td><td>2 (5%)</td><td>5 (14%)</td><td>7</td></tr><tr><td>9 (25%)</td><td>6 (17%)</td><td>8 (22%)</td><td>2... |
1b35df4929f68e558c8c93d43fbb4a77ef15e05b90ad462ac07eb0b1eab321b5.png | complex | <table><tr><td> </td><td>2009</td><td>2004-08</td><td>H1N1 Attributable</td><td>Rate Ratio: 2009:2004-08</td></tr><tr><td colspan="5">British Columbia</td></tr><tr><td>First Nations Reserves</td><td>13.77</td><td>9.48</td><td>4.29</td><td>1.45</td></tr><tr><td>Other Residents</td><td>6.65</td><td>6.18</td><td>0.47</td>... | <table><tr><td></td><td>2009</td><td>2004-08</td></tr><tr><td colspan="3">British Columbia</td></tr><tr><td>First Nations Reserves</td><td>13.77</td><td>9.48</td></tr><tr><td>Other Residents</td><td>6.65</td><td>6.18</td></tr><tr><td>Rate Ratio:</td><td rowspan="2">2.07</td><td rowspan="2">1.53</td></tr><tr><td>First N... | <table><tr><td>H1N1 Attributable</td><td>Rate Ratio: 2009:2004-08</td></tr><tr><td colspan="2">British Columbia</td></tr><tr><td>4.29</td><td>1.45</td></tr><tr><td>0.47</td><td>1.08</td></tr><tr><td rowspan="2">9.13</td><td rowspan="2">1.35*</td></tr><tr></tr><tr><td colspan="2">Manitoba</td></tr><tr><td>8.40</td><td>1... |
3d23dd5214fb5cecf3e8cd6ed693e0197401106f30e8c36110d4fb870a1d9400.png | simple | <table><tr><td>Dataset</td><td>DaliLite</td><td>TM-align</td><td>CE</td><td>MICAN</td><td>DEDAL</td><td>SNAP</td><td>GANGSTA+</td><td>SCALI</td><td>MASS</td><td>SAMO</td></tr><tr><td>MALIDUP-sq</td><td>85.3</td><td>81.0</td><td>62.3</td><td>85.8</td><td>83.4</td><td>70.8</td><td>64.4</td><td>56.2</td><td>50.4</td><td>4... | <table><tr><td>Dataset</td><td>DaliLite</td><td>TM-align</td><td>CE</td><td>MICAN</td><td>DEDAL</td><td>SNAP</td><td>GANGSTA+</td><td>SCALI</td><td>MASS</td><td>SAMO</td></tr><tr><td>MALIDUP-sq</td><td>85.3</td><td>81.0</td><td>62.3</td><td>85.8</td><td>83.4</td><td>70.8</td><td>64.4</td><td>56.2</td><td>50.4</td><td>4... | <table><tr><td>MALISAM-ns</td><td>21.7</td><td>22.5</td><td>—</td><td>67.6</td><td>56.1</td><td>43.6</td><td>29.9</td><td>37.5</td><td>20.4</td><td>8.5</td></tr></table> |
0c85fa6473b7266a435fc81971c3ea996167908c5b4d0aabe19a4ca1fcee68bb.png | complex | <table><tr><td rowspan="2">Color Choice</td><td colspan="3">Volunteer group</td><td rowspan="2">p value</td></tr><tr><td>HAD normal (n = 460) <i>No. (%) </i>Respondents</td><td>HAD anxious (n = 117) <i>No. (%) </i>Respondents</td><td>HAD depressed (n = 35) <i>No. (%) </i>Respondents</td></tr><tr><td>Positive</td><td>21... | <table><tr><td rowspan="2">Color Choice</td><td colspan="3">Volunteer group</td><td rowspan="2">p value</td></tr><tr><td>HAD normal (n = 460) No. (%) Respondents</td><td>HAD anxious (n = 117) No. (%) Respondents</td><td>HAD depressed (n = 35) No. (%) Respondents</td></tr><tr><td>Positive</td><td>212 (46.1%)</td><td>39 ... | <table><tr><td>Neutral</td><td>175 (38.0%)</td><td>44 (37.6%)</td><td>9 (25.7%)</td><td rowspan="2">Chi-square (4) = 33.656; p < 0.001</td></tr><tr><td>Negative</td><td>73 (15.9%)</td><td>34 (29.1%)</td><td>18 (51.4%)</td></tr></table> |
da0f451c63a024829d9d979c3e5515b1a4b043e8d0279ce0646ef6e355dfb261.png | simple | <table><tr><td>Use of CAM/conventional medicine</td><td>Frequency (%)</td></tr><tr><td>use only CAM</td><td>166 (51.1)</td></tr><tr><td>use combination of CAM and conventional medicine</td><td>159 (48.9)</td></tr><tr><td>Total</td><td>325 (100)</td></tr></table> | <table><tr><td>Use of CAM/conventional medicine</td></tr><tr><td>use only CAM</td></tr><tr><td>use combination of CAM and conventional medicine</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Frequency (%)</td></tr><tr><td>166 (51.1)</td></tr><tr><td>159 (48.9)</td></tr><tr><td>325 (100)</td></tr></table> |
c8c4e85b36b1c128aba2a3b0e5229c8accaa5c05e0caeb22f9f72f4bf7ac2a0f.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="2">Year of survey 2005</td><td colspan="2">Year of survey 2012</td><td rowspan="3">p</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Toilet</td><td> </td><td> </td><td> </td><td> </td><td>< 0.001</td></tr><tr><td>Absence</td><td>169</td><td>36.5<... | <table><tr><td rowspan="3">Variable</td><td colspan="2">Year of survey 2005</td><td colspan="2">Year of survey 2012</td><td rowspan="3">p</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td colspan="4"></td></tr><tr><td>Toilet</td><td></td><td></td><td></td><td></td><td>< 0.001</td></tr><tr><td>Absence</t... | <table><tr><td rowspan="3">Variable</td><td colspan="2">Year of survey 2005</td><td colspan="2">Year of survey 2012</td><td rowspan="3">p</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td colspan="4"></td></tr><tr><td>nking water</td><td></td><td></td><td></td><td></td><td>01*</td></tr><tr><td>Boiled/Fi... |
d6882188486d037365f9e28576b7b16cf41dccdf3d01431bf9907da556f11362.png | complex | <table><tr><td colspan="7">Cord plasma insulin</td></tr><tr><td> </td><td> </td><td colspan="2">Unadjusted analysis</td><td colspan="3">Adjusted analysis</td></tr><tr><td> </td><td>N</td><td>β</td><td>P-value</td><td>β</td><td>P-value</td><td>Adjusted model r<sup>2</sup></td></tr><tr><td>Week-1</td><td> </td>... | <table><tr><td colspan="7">Cord plasma insulin</td></tr><tr><td></td><td></td><td colspan="2">Unadjusted analysis</td><td colspan="3">Adjusted analysis</td></tr><tr><td></td><td>N</td><td>β</td><td>P-value</td><td>β</td><td>P-value</td><td>Adjusted model r2</td></tr><tr><td>Week-1</td><td></td><td></td><td></td><td></t... | <table><tr><td>Week-6</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SFT</td><td>40</td><td>0.294</td><td>0.065</td><td>0.292</td><td>0.146</td><td>0.122; p = 0.127</td></tr><tr><td>SCA</td><td>40</td><td>0.335</td><td>0.035</td><td>0.241</td><td>0.217</td><td>0.163; p = 0.074</td></tr><tr><td>P... |
7f0a95011e2fdc5f0009042ff0460c505e50bfa08d4138c5b12d5a00a1cb68eb.png | simple | <table><tr><td>Dam</td><td>Sire</td><td>Family</td><td>Contribution</td><td>Offspring males</td><td>Offspring females</td><td>Average weight in g (±se)</td><td>Average length in mm (±s.e)</td><td><i>P</i>-value</td></tr><tr><td>Dam 1</td><td>Sire 1</td><td>1</td><td>7.4 %</td><td>4</td><td>9</td><td>194.2 (58... | <table><tr><td>Dam</td><td>Sire</td><td>Family</td><td>Contribution</td><td>Offspring males</td><td>Offspring females</td><td>Average weight in g (±se)</td><td>Average length in mm (±s.e)</td><td>P-value</td></tr></table> | <table><tr><td>Dam 1</td><td>Sire 1</td><td>1</td><td>7.4 %</td><td>4</td><td>9</td><td>194.2 (58.7)</td><td>256.5 (20.9)</td><td>0.27</td></tr><tr><td>Dam 1</td><td>Sire 2</td><td>2</td><td>10.8 %</td><td>14</td><td>5</td><td>179.3 (34.1)</td><td>249.5 (15.3)</td><td>0.066</td></tr><tr><td>Dam 1</td><td>Sire 3</td><td... |
8c731812c7f9fdfc4d5485cba3a3ad2220a273b1b2321501d56f58be15b391d5.png | simple | <table><tr><td>RV Strain (Origin)</td><td>GenBank Accession number</td><td>P-type</td></tr><tr><td>RF (Bovine)</td><td>U65924</td><td>P[1]</td></tr><tr><td>SA11 (Simian)</td><td>M23188</td><td>P[2]</td></tr><tr><td>RRV (Simian)</td><td>M18736</td><td>P[3]</td></tr><tr><td>RV-5 (Human)</td><td>M32559</td><td>P[4]</td></... | <table><tr><td>RV Strain (Origin)</td><td>GenBank Accession number</td></tr><tr><td>RF (Bovine)</td><td>U65924</td></tr><tr><td>SA11 (Simian)</td><td>M23188</td></tr><tr><td>RRV (Simian)</td><td>M18736</td></tr><tr><td>RV-5 (Human)</td><td>M32559</td></tr><tr><td>UK (Bovine)</td><td>M22306</td></tr><tr><td>Gottfried (P... | <table><tr><td>P-type</td></tr><tr><td>P[1]</td></tr><tr><td>P[2]</td></tr><tr><td>P[3]</td></tr><tr><td>P[4]</td></tr><tr><td>P[5]</td></tr><tr><td>P[6]</td></tr><tr><td>P[7]</td></tr><tr><td>P[8]</td></tr><tr><td>P[9]</td></tr><tr><td>P[10]</td></tr><tr><td>P[11]</td></tr><tr><td>P[12]</td></tr><tr><td>P[13]</td></tr... |
b0dc6616b1739980ecea0d6f901012ddd226864d2234b7d5d3b2ee873c3f2fe3.png | simple | <table><tr><td></td><td>All Subjects</td><td>Non-abdominal obesity group</td><td>Abdominal obesity group</td><td><i>P</i></td></tr><tr><td>n</td><td>326</td><td>163</td><td>163</td><td></td></tr><tr><td>Age, y</td><td>45.1 ± 8.1</td><td>45.3 ± 8.4</td><td>44.8 ± 7.7</td><td>n.s.</td></tr><tr><td>Waist, c... | <table><tr><td></td><td>All Subjects</td><td>Non-abdominal obesity group</td><td>Abdominal obesity group</td><td>P</td></tr><tr><td>n</td><td>326</td><td>163</td><td>163</td><td></td></tr></table> | <table><tr><td>Age, y</td><td>45.1 ± 8.1</td><td>45.3 ± 8.4</td><td>44.8 ± 7.7</td><td>n.s.</td></tr><tr><td>Waist, cm</td><td>84.8 ± 8.2</td><td>78.3 ± 4.7</td><td>91.2 ± 5.2</td><td><0.0001</td></tr><tr><td>BMI, kg/m2</td><td>24.3 ± 3.3</td><td>22.1 ± 2.0</td><td>26.6 ± 2.8</td><td><0.0001</td></tr><tr><td>SBP, mmHg<... |
2fde017285e9cfc549986761dd4da62b16fb8f0ed31c7ca33910aaa4f032736f.png | simple | <table><tr><td></td><td>Conditioned taste aversion</td><td>Passive avoidance</td><td>Morris water maze 19°C</td><td>Morris water maze 23°C</td><td>Object recognition</td><td>Object location</td></tr><tr><td>Consolidation</td><td>No effect</td><td>No effect</td><td>No effect</td><td>No effect</td><td>Effect</t... | <table><tr><td></td><td>Conditioned taste aversion</td><td>Passive avoidance</td><td>Morris water maze 19°C</td><td>Morris water maze 23°C</td><td>Object recognition</td><td>Object location</td></tr><tr><td>Consolidation</td><td>No effect</td><td>No effect</td><td>No effect</td><td>No effect</td><td>Effect</td><td>Effe... | <table><tr><td></td><td>Conditioned taste aversion</td><td>Passive avoidance</td><td>Morris water maze 19°C</td><td>Morris water maze 23°C</td><td>Object recognition</td><td>Object location</td></tr><tr><td>Reconsolidation</td><td>Effect</td><td>Effect</td><td>No effect</td><td>No effect</td><td>Effect</td><td>Effect</... |
1d5bf653afc076112b1ec8897f10015429570eec6fafb5ff5bb266bb3965695c.png | simple | <table><tr><td></td><td>n</td><td>Mean age ± SD</td><td>T/S ratio ± SD</td><td>p*</td></tr><tr><td>OA patients</td><td>79</td><td>69.46 ± 8.97</td><td>0.986 ± 0.261</td><td>0.684</td></tr><tr><td>Healthy controls</td><td>166</td><td>51.92 ± 18.45</td><td>1.008 ± 0.287</td><td></td></tr><tr... | <table><tr><td></td><td>n</td><td>Mean age ± SD</td><td>T/S ratio ± SD</td><td>p*</td></tr><tr><td>OA patients</td><td>79</td><td>69.46 ± 8.97</td><td>0.986 ± 0.261</td><td>0.684</td></tr><tr><td>Healthy controls</td><td>166</td><td>51.92 ± 18.45</td><td>1.008 ± 0.287</td><td></td></tr></table> | <table><tr><td>Haplogroup J</td><td>155</td><td>52.97 ± 17.60</td><td>1.039 ± 0.287</td><td>0.003**</td></tr><tr><td>Non-J</td><td>90</td><td>65.22 ± 15.98</td><td>0.933 ± 0.254</td><td></td></tr></table> |
d5d053fd07e7caba8a9ed16ab378cc6122c047249106c243eaaa6fd23435f99b.png | simple | <table><tr><td> </td><td>N</td><td>Mean</td><td> </td><td>Increase</td></tr><tr><td>Age</td><td>(studies)</td><td>rate (%)<sup>†</sup></td><td>(95% CI)</td><td>of rates<sup>‡</sup></td></tr><tr><td>65-69</td><td>17</td><td>1.2</td><td>(0.8-1.5)</td><td> </td></tr><tr><td>70-74</td><td>19</td><td>3.7</td><td... | <table><tr><td></td></tr><tr><td>Age</td></tr><tr><td>65-69</td></tr><tr><td>70-74</td></tr><tr><td>75-79</td></tr><tr><td>80-84</td></tr><tr><td>85-89</td></tr><tr><td>90-94</td></tr><tr><td>>95</td></tr></table> | <table><tr><td>N</td><td>Mean</td><td></td><td>Increase</td></tr><tr><td>(studies)</td><td>rate (%)†</td><td>(95% CI)</td><td>of rates‡</td></tr><tr><td>17</td><td>1.2</td><td>(0.8-1.5)</td><td></td></tr><tr><td>19</td><td>3.7</td><td>(2.6-4.7)</td><td>3.0</td></tr><tr><td>21</td><td>7.9</td><td>(6.2-9.5)</td><td>2.1</... |
b85c6feea7060f2198373dd47f61c2a138e6fd1a0fdf61285227734bcadcf635.png | complex | <table><tr><td>Week</td><td colspan="2">Content and homework</td></tr><tr><td>1</td><td>Browser:</td><td>Psychoeducation:</td></tr><tr><td colspan="2"></td><td>Information about panic</td></tr><tr><td colspan="2"></td><td>Defining goals of training</td></tr><tr><td colspan="2"></td><td>Setting up a reward list</td></tr... | <table><tr><td>Week</td><td colspan="2">Content and homework</td></tr><tr><td>1</td><td>Browser:</td><td>Psychoeducation:</td></tr><tr><td colspan="2"></td><td>Information about panic</td></tr><tr><td colspan="2"></td><td>Defining goals of training</td></tr><tr><td colspan="2"></td><td>Setting up a reward list</td></tr... | <table><tr><td>Week</td><td colspan="2">Content and homework</td></tr><tr><td colspan="2"></td><td>Daily diary</td></tr><tr><td>5</td><td>Browser:</td><td>Cognitive restructuring II:</td></tr><tr><td colspan="2"></td><td>Reality testing of automatic negative thoughts</td></tr><tr><td></td><td>Mobile:</td><td>In vivo ex... |
5fba50cf2e6c66b53052b805e8017e5190bd8f1d710504436719b4dea7ec5865.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">n</td><td colspan="3">Time to go to sleep n (%)</td></tr><tr><td>Before 19:00</td><td>Between 19:00 and 21:00</td><td>Later</td></tr><tr><td colspan="5">Age group (years)</td></tr><tr><td> < 5</td><td>49</td><td>4 (8.2)</td><td>40 (88.9)</td><td>5 (11.1)</td></tr><tr><... | <table><tr><td rowspan="2"></td><td rowspan="2">n</td><td colspan="3">Time to go to sleep n (%)</td></tr><tr><td>Before 19:00</td><td>Between 19:00 and 21:00</td><td>Later</td></tr><tr><td colspan="5">Age group (years)</td></tr></table> | <table><tr><td colspan="5"></td></tr><tr><td>< 5</td><td>49</td><td>4 (8.2)</td><td>40 (88.9)</td><td>5 (11.1)</td></tr><tr><td>5–15</td><td>123</td><td>–</td><td>85 (69.1)</td><td>38 (30.9)</td></tr><tr><td>16–49</td><td>146</td><td>–</td><td>69 (47.3)</td><td>77 (52.7)</td></tr><tr><td>> 49</td><td>27</td><td>–</td><... |
e22a156d6840dc3e5b213463fb035b2d637bde2cd1f87b1425373ba5edba345d.png | complex | <table><tr><td></td><td>F</td><td>d.f.</td><td>P</td></tr><tr><td colspan="4">Size increase</td></tr><tr><td> Sex</td><td>4.95</td><td>1, 697</td><td>0.03</td></tr><tr><td> Treatment</td><td>0.20</td><td>1, 697</td><td>0.65</td></tr><tr><td> Sex × Treatment</td><td>0.60</td><td>1, 697</td><td>0.44</td></tr><tr><td... | <table><tr><td></td><td>F</td><td>d.f.</td><td>P</td></tr><tr><td colspan="4">Size increase</td></tr><tr><td>Sex</td><td>4.95</td><td>1, 697</td><td>0.03</td></tr><tr><td>Treatment</td><td>0.20</td><td>1, 697</td><td>0.65</td></tr><tr><td>Sex × Treatment</td><td>0.60</td><td>1, 697</td><td>0.44</td></tr><tr><td colspan... | <table><tr><td></td><td>F</td><td>d.f.</td><td>P</td></tr><tr><td>Sex</td><td>13</td><td>1, 697</td><td>0.0001</td></tr><tr><td>Treatment</td><td>6.46</td><td>1, 697</td><td>0.01</td></tr><tr><td>Sex × Treatment</td><td>1.19</td><td>1, 697</td><td>0.28</td></tr><tr><td colspan="4">Lifespan</td></tr><tr><td>Sex</td><td>... |
eb218d2465a15c7c1b771dd8995e65ea47581a21f0c9c4bbde22ed86f0e2e53e.png | simple | <table><tr><td>Tissue</td><td>Time (Months)</td><td>Control</td><td>Salmon b</td><td>Aimara c</td></tr><tr><td>Hair</td><td>3</td><td>3.4 ± 1.2</td><td>6.5 ± 2</td><td>242 ± 11 <sup>*</sup></td></tr><tr><td></td><td>14</td><td>33 ± 26</td><td>30 ± 8</td><td>733 ± 201 <sup>*</sup></td></tr>... | <table><tr><td>Tissue</td><td>Time (Months)</td><td>Control</td><td>Salmon b</td><td>Aimara c</td></tr><tr><td>Hair</td><td>3</td><td>3.4 ± 1.2</td><td>6.5 ± 2</td><td>242 ± 11 *</td></tr></table> | <table><tr><td>Tissue</td><td>Time (Months)</td><td>Control</td><td>Salmon b</td><td>Aimara c</td></tr><tr><td></td><td>14</td><td>33 ± 26</td><td>30 ± 8</td><td>733 ± 201 *</td></tr><tr><td>Kidney</td><td>3</td><td>12 ± 3</td><td>16 ± 2</td><td>359 ± 200 *</td></tr><tr><td></td><td>14</td><td>7 ± 2</td><td>21 ± 2 °</t... |
62a2ffa74587e400852c5d020adb05208b7f0a3ef0e3892985e5ddccbfa67e63.png | simple | <table><tr><td>Term</td><td>Prime number</td><td>Relation</td><td>Modified Gödel Number</td></tr><tr><td>Term1</td><td>2</td><td></td><td></td></tr><tr><td>Term2</td><td>3</td><td>R1: Term2 is a Term1</td><td>relation(is a) = 3 × 2 = 6</td></tr><tr><td>Term3</td><td>5</td><td>R2: Term3 is part of Term2</td><... | <table><tr><td>Term</td><td>Prime number</td><td>Relation</td><td>Modified Gödel Number</td></tr><tr><td>Term1</td><td>2</td><td></td><td></td></tr></table> | <table><tr><td>Term2</td><td>3</td><td>R1: Term2 is a Term1</td><td>relation(is a) = 3 × 2 = 6</td></tr><tr><td>Term3</td><td>5</td><td>R2: Term3 is part of Term2</td><td>relation(part of) = 5 × 3 × 2 = 30</td></tr><tr><td>Term4</td><td>7</td><td>R3: Term4 is a Term2</td><td>relation(is a) = 7 × 3 × 2 = 42</td></tr></t... |
dada9064195a0e132e4e634c7c9fce97cce266f3468d8930b5782fb7dfa9db35.png | complex | <table><tr><td>Table 3</td><td colspan="2">All grades</td><td colspan="2">Grade 3</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Skin</td><td>5</td><td>19</td><td>1</td><td>4</td></tr><tr><td>Lymph edema</td><td>3</td><td>12</td><td></td><td></td></tr><tr><td>Dysphagia</td><td>2</td><td>8</t... | <table><tr><td>Table 3</td><td colspan="2">All grades</td></tr><tr><td></td><td>n</td><td>%</td></tr><tr><td>Skin</td><td>5</td><td>19</td></tr><tr><td>Lymph edema</td><td>3</td><td>12</td></tr><tr><td>Dysphagia</td><td>2</td><td>8</td></tr><tr><td>Xerostomia</td><td>8</td><td>31</td></tr><tr><td>Loss of taste</td><td>... | <table><tr><td colspan="2">Grade 3</td></tr><tr><td>n</td><td>%</td></tr><tr><td>1</td><td>4</td></tr><tr><td></td><td></td></tr><tr><td>1</td><td>4</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td>2</td><td>8</td></tr><tr><td>1</td><td>4</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td><... |
7ce6d8f5c2c7d55bfc8fdb8ec61d3b145bb7522a356b9be83f9cef82ddfa793b.png | complex | <table><tr><td></td><td colspan="2">Health facility providers</td><td colspan="2">Pharmacists</td><td colspan="2">PMV operators</td></tr><tr><td>Minimum age</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td> Male condom</td><td>692</td><td>73.1</td><td>410</td><td>76.3</td><td>474</td><td>70.... | <table><tr><td></td><td colspan="2">Health facility providers</td><td colspan="2">Pharmacists</td><td colspan="2">PMV operators</td></tr><tr><td>Minimum age</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Male condom</td><td>692</td><td>73.1</td><td>410</td><td>76.3</td><td>474</td><td>70.7... | <table><tr><td>Injectable</td><td>1071</td><td>2.3***</td><td>289</td><td>1.5</td><td>na</td><td>na</td></tr><tr><td>IUD</td><td>560</td><td>2.1</td><td>na</td><td>na</td><td>na</td><td>na</td></tr><tr><td>Totala</td><td></td><td>3.7</td><td></td><td>3.6</td><td></td><td>3.8</td></tr></table> |
ec43243f7376d043f5df215d27e85492748ee92626fb20de97a8abe6ccfe67ed.png | simple | <table><tr><td> </td><td>Unadjusted OR (95% CI)</td><td>Adjusted OR (95% CI)*</td><td>Pv</td></tr><tr><td>Hillel Yaffe Medical Center vs. Carmel Medical Center</td><td>3.20 (1.53-6.69)</td><td>4.42 (1.70-11.46)</td><td>0.002</td></tr><tr><td>Arabs vs. Jews</td><td>2.30 (1.16-4.54)</td><td>2.32 (0.99-5.45)</td><td>0.05<... | <table><tr><td></td><td>Unadjusted OR (95% CI)</td><td>Adjusted OR (95% CI)*</td><td>Pv</td></tr></table> | <table><tr><td>Hillel Yaffe Medical Center vs. Carmel Medical Center</td><td>3.20 (1.53-6.69)</td><td>4.42 (1.70-11.46)</td><td>0.002</td></tr><tr><td>Arabs vs. Jews</td><td>2.30 (1.16-4.54)</td><td>2.32 (0.99-5.45)</td><td>0.05</td></tr><tr><td>Blood in the stool (yes vs. no)</td><td>1.98 (1.00-3.91)</td><td>2.78 (1.1... |
15514cc5a90695564bef791910882fa77a93a3398af8070946b7d3eb44a95aa3.png | simple | <table><tr><td>S.n</td><td>Criterion</td><td>Sensitivity</td><td>Specificity</td><td>PPV</td><td>NPV</td></tr><tr><td>1.</td><td>Size > 6 cm</td><td>0.95</td><td>0.57</td><td>0.67</td><td>0.93</td></tr><tr><td>2.</td><td>Size >8 cm</td><td>0.75</td><td>0.76</td><td>0.75</td><td>0.76</td></tr><tr><td>3.</td><td>Sh... | <table><tr><td>S.n</td><td>Criterion</td><td>Sensitivity</td><td>Specificity</td><td>PPV</td><td>NPV</td></tr><tr><td>1.</td><td>Size > 6 cm</td><td>0.95</td><td>0.57</td><td>0.67</td><td>0.93</td></tr><tr><td>2.</td><td>Size >8 cm</td><td>0.75</td><td>0.76</td><td>0.75</td><td>0.76</td></tr><tr><td>3.</td><td>Shape: i... | <table><tr><td>2.</td><td>moral calcification</td><td>0</td><td>.88</td><td>.85</td><td>0.76</td></tr><tr><td>13.</td><td>Absence of Intratumoral fat</td><td>1</td><td>0.07</td><td>0.5</td><td>1</td></tr><tr><td>14.</td><td>Absence of Intratumoral fibrosis</td><td>0.87</td><td>0.03</td><td>0.45</td><td>0.25</td></tr><t... |
56d9461a4b90fd8a153f0addb9928beb7d31da003e4ff482aeb64a583a82c315.png | simple | <table><tr><td></td><td>patients</td><td>EMD</td><td><i>p</i>*</td></tr><tr><td>pCR</td><td></td><td></td><td></td></tr><tr><td>pCR</td><td>19 (17.1)</td><td>6.1 ± 1.8</td><td>0.033</td></tr><tr><td>non-pCR</td><td>92 (82.9)</td><td>7.8 ± 3.2</td><td></td></tr><tr><td>TRG</td><td></td><td></td><td></td></tr><... | <table><tr><td></td><td>patients</td><td>EMD</td><td>p*</td></tr><tr><td>pCR</td><td></td><td></td><td></td></tr><tr><td>pCR</td><td>19 (17.1)</td><td>6.1 ± 1.8</td><td>0.033</td></tr><tr><td>non-pCR</td><td>92 (82.9)</td><td>7.8 ± 3.2</td><td></td></tr><tr><td>TRG</td><td></td><td></td><td></td></tr><tr><td>TRG 0–1</t... | <table><tr><td>TRG 2–3</td><td>61 (55.0)</td><td>7.7 ± 3.1</td><td></td></tr><tr><td>Downstaging</td><td></td><td></td><td></td></tr><tr><td>ypStage 0–I</td><td>42 (37.8)</td><td>7.1 ± 3.0</td><td>0.258</td></tr><tr><td>ypStage II–III</td><td>69 (62.2)</td><td>7.8 ± 3.1</td><td></td></tr></table> |
610213039934f2d2fc254baf8f245a05b773f131decc82ae966a15a39fcd1407.png | complex | <table><tr><td rowspan="2">Scales</td><td rowspan="2">PANSS</td><td rowspan="2">AIMS</td><td rowspan="2">BAS</td><td rowspan="2">SAS</td><td>AP (mg)</td><td>DUI</td><td>AGE</td><td>Subtype</td><td rowspan="2">Calgary</td></tr><tr><td>(CPZ equiv.)</td><td>(years)</td><td>(years)</td><td>(<i>n</i>)</td></tr><tr><td>Group... | <table><tr><td rowspan="2">Scales</td><td rowspan="2">PANSS</td><td rowspan="2">AIMS</td><td rowspan="2">BAS</td><td rowspan="2">SAS</td><td>AP (mg)</td><td>DUI</td><td>AGE</td><td>Subtype</td><td rowspan="2">Calgary</td></tr><tr><td>(CPZ equiv.)</td><td>(years)</td><td>(years)</td><td>(n)</td></tr><tr><td>Groups Contr... | <table><tr><td>AA (N = 5)</td><td>74.40/</td><td>3.40/</td><td>0.40/</td><td>1.20/</td><td>565.45/</td><td>11.00/</td><td>33.20/</td><td>Paranoid (2)</td><td>6.40 ± 2.07</td></tr><tr><td>m/sd</td><td>13.51</td><td>1.82</td><td>0.55</td><td>0.84</td><td>404.03</td><td>8.94</td><td>9.60</td><td>Undiffer. (3)</td><td></td... |
a65b3fa78de4a08040ebc7663de77b89fc1becdccd080b415282ed9c96c0eb9a.png | complex | <table><tr><td> </td><td> </td><td colspan="3">Prevalence of TT post-intervention (cases per 1000 persons)</td><td colspan="3">Incidence of CO post-intervention (cases per 10,000 persons per annum)</td></tr><tr><td>Intervention</td><td>Intensity of control effort</td><td>5 years</td><td>10 years</td><td>20 years</td><t... | <table><tr><td></td><td></td><td colspan="3">Prevalence of TT post-intervention (cases per 1000 persons)</td><td colspan="3">Incidence of CO post-intervention (cases per 10,000 persons per annum)</td></tr><tr><td>Intervention</td><td>Intensity of control effort</td><td>5 years</td><td>10 years</td><td>20 years</td><td>... | <table><tr><td></td><td>Medium</td><td>3.1</td><td>3.6</td><td>3.6</td><td>1.1</td><td>1.2</td><td>1.2</td></tr><tr><td></td><td>High</td><td>1.4</td><td>1.6</td><td>1.7</td><td>0.5</td><td>0.5</td><td>0.6</td></tr><tr><td>S + TR</td><td>Low</td><td>9.1</td><td>6.4</td><td>3.1</td><td>3.2</td><td>2.2</td><td>1.1</td></... |
2d9b0ad3980b6a2ad76e0311007918cc941d386e04fcfa387ccbbd4e37d50e10.png | complex | <table><tr><td></td><td colspan="3">WCO</td><td colspan="3">BEO</td></tr><tr><td></td><td>Searches</td><td>Avg.</td><td>Searches</td><td>Searches</td><td>Avg.</td><td>Searches</td></tr><tr><td></td><td></td><td>Time (s)</td><td>per s</td><td></td><td>Time (s)</td><td>per s</td></tr><tr><td>LS</td><td>879</td><td>0.095<... | <table><tr><td></td><td colspan="3">WCO</td><td colspan="3">BEO</td></tr><tr><td></td><td>Searches</td><td>Avg.</td><td>Searches</td><td>Searches</td><td>Avg.</td><td>Searches</td></tr><tr><td></td><td></td><td>Time (s)</td><td>per s</td><td></td><td>Time (s)</td><td>per s</td></tr></table> | <table><tr><td>LS</td><td>879</td><td>0.095</td><td>9253</td><td>2032</td><td>0.1317</td><td>15429</td></tr><tr><td>GACT</td><td>146430</td><td>4.32</td><td>33896</td><td>30850</td><td>1.01</td><td>30433</td></tr><tr><td>HC</td><td>300650</td><td>13.82</td><td>21749</td><td>299580</td><td>11.41</td><td>26256</td></tr><... |
ebd5020e58826f60ed8b99d6a93e4393fdcbfc06aed6ac48a75dcf4e12f07273.png | simple | <table><tr><td>miRNA</td><td>*activated vs resting</td><td><i>Q</i> value</td></tr><tr><td><i>mir-211</i></td><td>Down</td><td>0.0026</td></tr><tr><td><i>miR-148a</i></td><td>Up</td><td>0.0340</td></tr><tr><td><i>mir-141</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>miR-155</i></td><td>Up</td><td>0.0445</td></tr>... | <table><tr><td>miRNA</td><td>*activated vs resting</td><td>Q value</td></tr><tr><td>mir-211</td><td>Down</td><td>0.0026</td></tr><tr><td>miR-148a</td><td>Up</td><td>0.0340</td></tr><tr><td>mir-141</td><td>Down</td><td>0.0445</td></tr><tr><td>miR-155</td><td>Up</td><td>0.0445</td></tr><tr><td>mir-184</td><td>Down</td><t... | <table><tr><td>miRNA</td><td>*activated vs resting</td><td>Q value</td></tr><tr><td>miR-516-3p</td><td>Down</td><td>0.0448</td></tr><tr><td>miR-106a</td><td>Up</td><td>0.0500</td></tr><tr><td>miR-21</td><td>Up</td><td>0.0500</td></tr><tr><td>miR-95</td><td>Down</td><td>0.0551</td></tr><tr><td>miR-20b</td><td>Up</td><td... |
96eb85e26ea45e55c096cb77730de361060a2e80f6694b5abe9faf26e84f00cf.png | simple | <table><tr><td>Health outcome</td><td>Studies exploring associations with weather/climate</td><td>Studies projecting the health impacts of climate change</td></tr><tr><td>Heat waves</td><td>++</td><td>+</td></tr><tr><td>Other extreme events</td><td>+</td><td>0</td></tr><tr><td>Waterborne and foodborne diseases</td><td>... | <table><tr><td>Health outcome</td><td>Studies exploring associations with weather/climate</td><td>Studies projecting the health impacts of climate change</td></tr><tr><td>Heat waves</td><td>++</td><td>+</td></tr><tr><td>Other extreme events</td><td>+</td><td>0</td></tr><tr><td>Waterborne and foodborne diseases</td><td>... | <table><tr><td>Other health impacts including mental health, nutritional issues related to food security, and population displacement</td><td>+</td><td>0</td></tr></table> |
2966ba1d6512c72e3bfe2b2b20c96799a96bd42e3f309ece5821be75ed68e3f8.png | simple | <table><tr><td> </td><td>First assessment, first test (n = 63)</td><td>First assessment, second test (n = 63)</td><td>P-value for group difference†</td><td>Second assessment, first test (n = 61)</td><td>Second assessment, second test (n = 61)</td><td>P-value for group difference†</td></tr><tr><td>Neck flexo... | <table><tr><td></td><td>First assessment, first test (n = 63)</td><td>First assessment, second test (n = 63)</td><td>P-value for group difference†</td><td>Second assessment, first test (n = 61)</td><td>Second assessment, second test (n = 61)</td><td>P-value for group difference†</td></tr><tr><td>Neck flexor muscle endu... | <table><tr><td></td><td>First assessment, first test (n = 63)</td><td>First assessment, second test (n = 63)</td><td>P-value for group difference†</td><td>Second assessment, first test (n = 61)</td><td>Second assessment, second test (n = 61)</td><td>P-value for group difference†</td></tr><tr><td>exor muscle endurance t... |
4de3e8a14ee658177fc30eea46ee1434fcc6cc8a3f67b690de198851f4a48a22.png | simple | <table><tr><td>Parameters</td><td>Soda Wheat Straw BL <sup>1</sup></td><td>Soda Barley Straw BL <sup>1</sup></td><td>Soda-AQ <sup>3</sup><i>Leucaena</i> BL <sup>1</sup></td><td>Soda-AQ <sup>3</sup><i>Chamaecytisus</i> BL <sup>1</sup></td></tr><tr><td>pH</td><td>10.72 ± 0.16</td><td>10.24 ± 0.011</td><td>9.85 ... | <table><tr><td>Parameters</td><td>Soda Wheat Straw BL 1</td><td>Soda Barley Straw BL 1</td><td>Soda-AQ 3Leucaena BL 1</td><td>Soda-AQ 3Chamaecytisus BL 1</td></tr><tr><td>pH</td><td>10.72 ± 0.16</td><td>10.24 ± 0.011</td><td>9.85 ± 0.005</td><td>10.47 ± 0.006</td></tr><tr><td>Density (g/mL)</td><td>1.011 ± 0.002</td><t... | <table><tr><td>l (g/L)</td><td>0.00</td><td>.00</td><td>00</td><td>0</td></tr><tr><td>Electrical conductivity (mS/cm)</td><td>14.63 ± 0.01</td><td>13.007 ± 0.005</td><td>21.7 ± 0.42</td><td>21.4 ± 0.06</td></tr></table> |
e4c71ef41be5bcdc7a199ef116701b7498391b99f464274c77d3951fb9ffc8a2.png | simple | <table><tr><td>Serial number</td><td>Dose (mg/ml)</td><td>Size of NPs (nm)</td><td>Time (h)</td><td>Head</td><td>Tail</td><td>Comet</td><td>Head DNA</td><td>Tail DNA</td><td>Tail moment</td><td>Olive tail moment</td></tr><tr><td>1</td><td>0.0</td><td>Nil</td><td>0</td><td>51</td><td>52</td><td>103</td><td>72.62</td><td... | <table><tr><td>Serial number</td><td>Dose (mg/ml)</td><td>Size of NPs (nm)</td><td>Time (h)</td><td>Head</td><td>Tail</td><td>Comet</td><td>Head DNA</td><td>Tail DNA</td><td>Tail moment</td><td>Olive tail moment</td></tr><tr><td>1</td><td>0.0</td><td>Nil</td><td>0</td><td>51</td><td>52</td><td>103</td><td>72.62</td><td... | <table><tr><td>Serial number</td><td>Dose (mg/ml)</td><td>Size of NPs (nm)</td><td>Time (h)</td><td>Head</td><td>Tail</td><td>Comet</td><td>Head DNA</td><td>Tail DNA</td><td>Tail moment</td><td>Olive tail moment</td></tr><tr><td></td><td></td><td>0</td><td>2</td><td>50</td><td>1</td><td></td><td>.62</td><td></td><td></... |
a66430e2942fd55505a353922a8e734286c72e2812e84220b5b24ee6ed380206.png | simple | <table><tr><td></td><td>VAI</td><td>WC</td><td>WHtR</td><td>P-value (compare WC and VAI)</td><td>P-value (compare WHtR and VAI)</td></tr><tr><td>Composite outcomes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T = 4 years</td><td>60.85 ± 2.87</td><td>59.26 ± 3.09</td><td>59.98 ± 3.07</td>... | <table><tr><td></td><td>VAI</td><td>WC</td><td>WHtR</td><td>P-value (compare WC and VAI)</td><td>P-value (compare WHtR and VAI)</td></tr><tr><td>Composite outcomes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T = 4 years</td><td>60.85 ± 2.87</td><td>59.26 ± 3.09</td><td>59.98 ± 3.07</td><td>0.63</td><t... | <table><tr><td></td><td>VAI</td><td>WC</td><td>WHtR</td><td>P-value (compare WC and VAI)</td><td>P-value (compare WHtR and VAI)</td></tr><tr><td>CV outcomes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T = 4 years</td><td>63.12 ± 3.06</td><td>62.23 ± 3.38</td><td>63.26 ± 3.36</td><td>0.80</td><td>0.97<... |
006dd7b1bbfe895b7395ab5f3f5de440380162aca0185de3f4bed5daa4ae8d3b.png | simple | <table><tr><td> </td><td>≤44 yrs</td><td>45 – 59 yrs</td><td>60 – 74 yrs</td><td>≥75 yrs</td></tr><tr><td>Indication</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Ischemia/CAD</td><td>12.1%</td><td>37.7%</td><td>48.1%</td><td>49.5%</td></tr><tr><td>Myocarditis/CMP</td><td>63.6%</td><t... | <table><tr><td></td></tr><tr><td>Indication</td></tr><tr><td>Ischemia/CAD</td></tr><tr><td>Myocarditis/CMP</td></tr><tr><td>Viability</td></tr><tr><td>Stress CMR</td></tr><tr><td>Image quality</td></tr><tr><td>Good</td></tr><tr><td>Moderate</td></tr><tr><td>Poor</td></tr><tr><td>Complications</td></tr><tr><td>None</td>... | <table><tr><td>≤44 yrs</td><td>45 – 59 yrs</td><td>60 – 74 yrs</td><td>≥75 yrs</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>12.1%</td><td>37.7%</td><td>48.1%</td><td>49.5%</td></tr><tr><td>63.6%</td><td>36.6%</td><td>22.5%</td><td>16.5%</td></tr><tr><td>5.3%</td><td>17.0%</td><td>19.2%</td><td>22.4%</t... |
41833138f18448ae3f68d39982db492fe64564353de71e667983f5545c586281.png | simple | <table><tr><td></td><td>TC (mmol/L)</td><td>TG (mmol/L)</td><td>HDL (mmol/L)</td><td>LDL (mmol/L)</td></tr><tr><td>control</td><td>13.8 ± 0.3</td><td>1.4 ± 0.2</td><td>3.7 ± 0.9</td><td>8.2 ± 0.8</td></tr><tr><td>agmatine</td><td>19 ± 4.1(<i>p</i> = 0.052)</td><td>1.7 ± 0.6 (NS)</td><td>8.... | <table><tr><td></td><td>TC (mmol/L)</td><td>TG (mmol/L)</td><td>HDL (mmol/L)</td><td>LDL (mmol/L)</td></tr><tr><td></td><td>13.8 ± 0.</td><td>1.</td><td>3.7 ± </td><td>8</td></tr></table> | <table><tr><td>control</td><td>3</td><td>4 ± 0.2</td><td>0.9</td><td>.2 ± 0.8</td></tr><tr><td>agmatine</td><td>19 ± 4.1(p = 0.052)</td><td>1.7 ± 0.6 (NS)</td><td>8.6 ± 1.8 *</td><td>11.7 ± 2.4 (NS)</td></tr></table> |
7e2647202ebcec61d22444bd28abf58f639db57621b9217dda466bb55ebc8c86.png | complex | <table><tr><td>Exposure variables<sup>a</sup>\Percentile<sup>b</sup></td><td>Min</td><td>5th</td><td>25th</td><td>50th</td><td>75th</td><td>95th</td><td>Max</td></tr><tr><td colspan="8">As metabolites (μg g<sup>−1</sup> crea)</td></tr><tr><td>MMA</td><td>0.06</td><td>0.08</td><td>0.19</td><td>0.40 (1.10)<sup... | <table><tr><td>Exposure variablesa\Percentileb</td><td>Min</td></tr><tr><td colspan="2">As metabolites (μg g−1 crea)</td></tr><tr><td>MMA</td><td>0.06</td></tr><tr><td>DMA</td><td>0.07</td></tr><tr><td>iAs</td><td>0.11</td></tr><tr><td>tAs</td><td>0.34</td></tr></table> | <table><tr><td>5th</td><td>25th</td><td>50th</td><td>75th</td><td>95th</td><td>Max</td></tr><tr><td colspan="6">As metabolites (μg g−1 crea)</td></tr><tr><td>0.08</td><td>0.19</td><td>0.40 (1.10)c</td><td>1.67</td><td>6.14</td><td>28.5</td></tr><tr><td>3.09</td><td>11.27</td><td>20.73 (14.58)</td><td>29.5</td><td>70.75... |
f6ba78ad7c8c0c272d793c9e89db3cd45cec8d1152b7f9d738fcbe3da43ed55c.png | complex | <table><tr><td></td><td colspan="5">Self-rated health</td></tr><tr><td></td><td>Improved</td><td>Worsening</td><td>Sustained good</td><td>Sustained poor</td><td>Total</td></tr><tr><td></td><td>277 (6)</td><td>556 (13)</td><td>2864 (68)</td><td>543 (13)</td><td>4240 (100)</td></tr><tr><td>Sex</td><td></td><td></td><td><... | <table><tr><td></td><td colspan="5">Self-rated health</td></tr><tr><td></td><td>Improved</td><td>Worsening</td><td>Sustained good</td><td>Sustained poor</td><td>Total</td></tr><tr><td></td><td>277 (6)</td><td>556 (13)</td><td>2864 (68)</td><td>543 (13)</td><td>4240 (100)</td></tr><tr><td>Sex</td><td></td><td></td><td><... | <table><tr><td>Further</td><td>162 (7)</td><td>282 (12)</td><td>1697 (70)</td><td>268 (11)</td><td>2401 (100)</td></tr><tr><td>Non-academic</td><td>115 (6)</td><td>274 (15)</td><td>1167 (63)</td><td>275 (15)</td><td>1839 (100)</td></tr><tr><td colspan="6">Managerial responsibility at baseline</td></tr><tr><td>Top manag... |
9fd85511db4b9224e313b8df0d205e7cb487b2c329edbbf4a2a0fcb0bede1291.png | simple | <table><tr><td>microRNA</td><td>Inhibitor Agent</td><td>Type of Disease</td><td>Investigation Status</td><td>Company/Ref</td></tr><tr><td>miR-10b</td><td>ASO</td><td>Glioblastoma</td><td>Preclinical</td><td>Regulus Therapeutics [108]</td></tr><tr><td>miR-21</td><td>ASO</td><td>HCC, fibrosis</td><td>Preclinical</td><td>... | <table><tr><td>microRNA</td><td>Inhibitor Agent</td><td>Type of Disease</td><td>Investigation Status</td><td>Company/Ref</td></tr><tr><td>miR-10b</td><td>ASO</td><td>Glioblastoma</td><td>Preclinical</td><td>Regulus Therapeutics [108]</td></tr><tr><td>miR-21</td><td>ASO</td><td>HCC, fibrosis</td><td>Preclinical</td><td>... | <table><tr><td>5</td><td>-modified</td><td>goides</td><td>e I</td><td>n Therapeutics [111]</td></tr><tr><td>miR-221</td><td>ASO</td><td>Pancreatic carcinoma</td><td>Preclinical</td><td>Regulus Therapeutics [110]</td></tr><tr><td>miR-122</td><td>LNA-modified</td><td>HCV</td><td>Phase II</td><td>Santaris Pharma [112,113]... |
c0eb25060b8662f3d3a916e78347f70e34495129aaf159aa158f3ae4cd17a7d6.png | complex | <table><tr><td rowspan="2">Clinical variables</td><td colspan="2">PFS</td><td colspan="2">OS</td></tr><tr><td>HR (95%CI)</td><td><i>P</i> value</td><td>HR (95%CI)</td><td><i>P</i> value</td></tr><tr><td>Univariate analysis</td><td></td><td></td><td></td><td></td></tr><tr><td>Age</td><td>0.999 (0.975-1.023)</td><td>0.91... | <table><tr><td rowspan="2">Clinical variables</td><td colspan="2">PFS</td><td>OS</td></tr><tr><td>HR (95%CI)</td><td>P value</td><td>HR (95%CI)</td></tr><tr><td>Univariate analysis</td><td></td><td></td><td></td></tr><tr><td>Age</td><td>0.999 (0.975-1.023)</td><td>0.915</td><td>1.003 (0.977-1.030)</td></tr><tr><td>Hist... | <table><tr><td>OS</td></tr><tr><td>P value</td></tr><tr><td></td></tr><tr><td>0.814</td></tr><tr><td>0.282</td></tr><tr><td>0.296</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td>0.001</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td></td><... |
005bc06d6056f0d26fba21be7d8d62379886acead49327c1ae44ed1ba2fa7762.png | simple | <table><tr><td>Evidence code type</td><td>Evidence code</td><td>Annotation errors</td><td>Total annotations</td><td>Percentage error rate</td></tr><tr><td>Experimental(manually assigned)</td><td>EXP</td><td>977</td><td>5360</td><td>18.23</td></tr><tr><td></td><td>IDA</td><td>12</td><td>105764</td><td>0.01</td></tr><tr>... | <table><tr><td>Evidence code type</td><td>Evidence code</td><td>Annotation errors</td><td>Total annotations</td><td>Percentage error rate</td></tr><tr><td>Experimental(manually assigned)</td><td>EXP</td><td>977</td><td>5360</td><td>18.23</td></tr><tr><td></td><td>IDA</td><td>12</td><td>105764</td><td>0.01</td></tr><tr>... | <table><tr><td></td><td>NAS</td><td>3</td><td>3578</td><td></td></tr><tr><td>Curator statement(manually assigned)</td><td>IC</td><td>0</td><td>5682</td><td>0.00</td></tr><tr><td></td><td>ND</td><td>0</td><td>171817</td><td>0.00</td></tr><tr><td>Automatically Assigned</td><td>IEA</td><td>639</td><td>844441</td><td>0.08<... |
2d7ec28cd4a544c5c752fae124644d45267581f3fe146a7086a09cf2424cd84a.png | simple | <table><tr><td>Image</td><td>Speed up</td></tr><tr><td>Spine (MRI)</td><td>32.7%</td></tr><tr><td>Chest (X-ray)</td><td>33.1%</td></tr><tr><td>Fetus (ultrasonic)</td><td>52.7%</td></tr><tr><td>Head (CT)</td><td>53.6%</td></tr></table> | <table><tr><td>Image</td><td>Speed up</td></tr><tr><td>Spine (MRI)</td><td>32</td></tr></table> | <table><tr><td>Image</td><td>Speed up</td></tr><tr><td></td><td>.7%</td></tr><tr><td>Chest (X-ray)</td><td>33.1%</td></tr><tr><td>Fetus (ultrasonic)</td><td>52.7%</td></tr><tr><td>Head (CT)</td><td>53.6%</td></tr></table> |
665b155221e17eae750efe20c63c926c162f49791720c4f2654509f14bee91b9.png | simple | <table><tr><td>Primer target</td><td>Primer sequence (5′ to 3′)</td></tr><tr><td><i>Pgc-1α-a </i>F</td><td>GCTTGACTGGCGTCATTCG</td></tr><tr><td><i>Pgc-1α-a </i>R</td><td>ACAGAGTCTTGGCTGCACATGT</td></tr><tr><td><i>Pgc-1α-b </i>F</td><td>GACATGGATGTTGGGATTGTCA</td></tr><tr><td><i>Pgc-1α-b ... | <table><tr><td>Primer target</td><td>Primer sequence (5′ to 3′)</td></tr><tr><td>Pgc-1α-a F</td><td>GCTTGACTGGCGTCATTCG</td></tr></table> | <table><tr><td>Primer target</td><td>Primer sequence (5′ to 3′)</td></tr><tr><td>Pgc-1α-a R</td><td>ACAGAGTCTTGGCTGCACATGT</td></tr><tr><td>Pgc-1α-b F</td><td>GACATGGATGTTGGGATTGTCA</td></tr><tr><td>Pgc-1α-b R</td><td>ACCAACCAGAGCAGCACATTT</td></tr><tr><td>Pgc-1α-c F</td><td>AGTGACATGGATGTTGGGATTG</td></tr><tr><td>Pgc-... |
937e85ddfe5bc19196b45fddb12efb5b8220088bcf60c528fb7bc71efecdbc44.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Status of LLIN usage number (%)</td><td rowspan="2">Crude OR (95 % CI)</td><td rowspan="2">Adjusted OR (95 % CI)<sup>a</sup></td><td rowspan="2">p-value</td></tr><tr><td>Yes N = 11,574</td><td>No N = 2876</td></tr><tr><td colspan="6"><i>Age categories</i> (<i>year... | <table><tr><td rowspan="2">Variable</td></tr><tr></tr><tr><td>Age categories (years)</td></tr><tr><td>0–5</td></tr><tr><td>6–14</td></tr><tr><td>15–45</td></tr><tr><td>>45</td></tr><tr><td>Gender</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Number of household members</td></tr><tr><td>1</td></tr><tr><... | <table><tr><td colspan="2">Status of LLIN usage number (%)</td><td rowspan="2">Crude OR (95 % CI)</td><td rowspan="2">Adjusted OR (95 % CI)a</td><td rowspan="2">p-value</td></tr><tr><td>Yes N = 11,574</td><td>No N = 2876</td></tr><tr><td colspan="5">Age categories (years)</td></tr><tr><td>2511 (83.12)</td><td>510 (16.8... |
ca5b204d1e82faa4fad71ee0ce84e490256bd8ba6b9197d4f5837e050c3ad8ee.png | complex | <table><tr><td rowspan="2">Item</td><td colspan="4">Factor<sup>a</sup></td></tr><tr><td>I</td><td>II</td><td>III</td><td>IV</td></tr><tr><td>10. Surfing</td><td>.74</td><td>-.07</td><td>-.02</td><td>-.14</td></tr><tr><td>12. Flying Plane</td><td>.79</td><td>-.04</td><td>.09</td><td>-.12</td></tr><tr><td>13. Diving</td>... | <table><tr><td rowspan="2">Item</td><td colspan="4">Factora</td></tr><tr><td>I</td><td>II</td><td>III</td><td>IV</td></tr><tr><td>10. Surfing</td><td>.74</td><td>-.07</td><td>-.02</td><td>-.14</td></tr><tr><td>12. Flying Plane</td><td>.79</td><td>-.04</td><td>.09</td><td>-.12</td></tr><tr><td>13. Diving</td><td>.54</td... | <table><tr><td>5. Marihuana</td><td>.04</td><td>-.11</td><td>.99</td><td>-.07</td></tr><tr><td>6. Hallucinogens Drugs</td><td>.01</td><td>.06</td><td>.90</td><td>-.08</td></tr><tr><td>9. Stimulants</td><td>-.08</td><td>.27</td><td>.60</td><td>.17</td></tr><tr><td>22. Dangerous Drugs</td><td>-.10</td><td>.34</td><td>.46... |
cfa3b384438e4c9b38984416790c725bb5eb03789da5399e83706e6be4fe08d2.png | complex | <table><tr><td>Components</td><td>Composite Alpha</td><td>Extracted variance</td><td>Interobserver Reliability<sup>a</sup></td><td>Item</td><td>Stand<sup>b</sup></td><td>Var. Error</td><td>Factor loading<sup>c</sup></td><td>Convergent validity<sup>d</sup></td><td>Discriminant validity</td></tr><tr><td rowspan="3">Compo... | <table><tr><td>Components</td><td>Composite Alpha</td><td>Extracted variance</td><td>Interobserver Reliabilitya</td><td>Item</td><td>Standb</td><td>Var. Error</td><td>Factor loadingc</td><td>Convergent validityd</td><td>Discriminant validity</td></tr><tr><td rowspan="2">Component 1</td><td rowspan="2">0.79</td><td rows... | <table><tr><td>Component 1</td><td>0.79</td><td>0.56</td><td>84.9</td><td>Pain</td><td>0.89</td><td>0.21</td><td>0.81</td><td>6.68</td><td rowspan="3">0.50</td></tr><tr><td rowspan="2">Component 2</td><td rowspan="2">0.71</td><td rowspan="2">0.55</td><td rowspan="2">87.9</td><td>Abscess</td><td>0.71</td><td>0.49</td><t... |
9629a756ed2ac80506e9e86a7fbe0b3f1e2dcf4da0b03f1083dd02e3aabf6d77.png | complex | <table><tr><td><i>LVH classification</i></td><td><i>LVH status</i></td><td><i>Total population QTd (ms)</i></td><td>p<i>-value</i></td><td><i>Normotensive group QTd (ms)</i></td><td>p<i>-value</i></td><td><i>Prehypertensive group QTd (ms)</i></td><td>p<i>-value</i></td></tr><tr><td rowspan="2">Sokolow–Lyon</td><t... | <table><tr><td>LVH classification</td><td>LVH status</td><td>Total population QTd (ms)</td><td>p-value</td><td>Normotensive group QTd (ms)</td><td>p-value</td><td>Prehypertensive group QTd (ms)</td><td>p-value</td></tr><tr><td>Sokolow–Lyon</td><td>No LVH</td><td>38.77 ± 11.31</td><td>0.88</td><td>39.11 ± 11.10</td><td>... | <table><tr><td>Sokolow–Lyon</td><td>LVH</td><td>38.13 ± 12.39</td><td></td><td>37.00 ± 11.94</td><td></td><td>39.25 ± 14.57</td><td></td></tr><tr><td rowspan="2">Araoye</td><td>No LVH</td><td>38.78 ± 10.78</td><td>0.88</td><td>39.36 ± 10.89</td><td>0.33</td><td>39.97 ± 10.67</td><td>0.54</td></tr><tr><td>LVH</td><td>38... |
1f0b1d75f5460db085495eaaf4eb6e5e78fdf8f9b23a4909fa72841cf2f7c946.png | complex | <table><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>Overweight OR (95% CI)</td><td>Obese OR (95% CI)</td><td>Overweight OR (95% CI)</td><td>Obese OR (95% CI)</td></tr><tr><td>White</td><td>Ref</td><td>Ref</td><td>Ref</td><td>Ref</td></tr><tr><td>Black</td><td>2.20 (1.54, 3.15)</t... | <table><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>Overweight OR (95% CI)</td><td>Obese OR (95% CI)</td><td>Overweight OR (95% CI)</td><td>Obese OR (95% CI)</td></tr><tr><td>White</td><td>Ref</td><td>Ref</td><td>Ref</td><td>Ref</td></tr><tr><td>Black</td><td>2.20 (1.54, 3.15)</t... | <table><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td>Other</td><td>1.04 (0.48, 2.23)</td><td>1.21 (0.23, 5.27)</td><td>1.58 (0.57, 4.35)</td><td>3.94 (0.94, 15.53)</td></tr></table> |
31e41ef606ebee6a642c8f3a76357e8833b2a8f5c46a423dcbf1a341141c65c5.png | complex | <table><tr><td></td><td colspan="9">Study period (weeks)</td></tr><tr><td>Time point</td><td>3/16</td><td>4/16</td><td>5/16</td><td>6/16</td><td>7/16</td><td>8/16</td><td>9/16</td><td>10/16</td><td>11/16</td></tr><tr><td colspan="10">Enrolment</td></tr><tr><td> Recruitment</td><td>X</td><td>X</td><td>X</td><td>X</td><t... | <table><tr><td></td><td colspan="9">Study period (weeks)</td></tr><tr><td>Time point</td><td>3/16</td><td>4/16</td><td>5/16</td><td>6/16</td><td>7/16</td><td>8/16</td><td>9/16</td><td>10/16</td><td>11/16</td></tr><tr><td colspan="10">Enrolment</td></tr><tr><td>Recruitment</td><td>X</td><td>X</td><td>X</td><td>X</td><td... | <table><tr><td></td><td colspan="9">Study period (weeks)</td></tr><tr><td>Time point</td><td>3/16</td><td>4/16</td><td>5/16</td><td>6/16</td><td>7/16</td><td>8/16</td><td>9/16</td><td>10/16</td><td>11/16</td></tr><tr><td>Discussion group</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td>... |
7e7a8fc012348ae8ebb61ae0f1da056197e35c03cebf95612e172320607f0452.png | complex | <table><tr><td rowspan="2">Current year</td><td colspan="4">Next year</td></tr><tr><td>Breeders, %</td><td><i>N</i></td><td>Failed breeders, %</td><td><i>N</i></td></tr><tr><td>Breeders</td><td>78.9</td><td>172</td><td>21.1</td><td>46</td></tr><tr><td>Failed breeders</td><td>82.0</td><td>50</td><td>18.0</td><td>11</td>... | <table><tr><td rowspan="2">Cu</td><td colspan="4">Next year</td></tr><tr><td></td><td></td><td>Failed b</td><td>N</td></tr></table> | <table><tr><td>rrent year</td><td>Breeders, %</td><td>N</td><td>reeders, %</td><td></td></tr><tr><td>Breeders</td><td>78.9</td><td>172</td><td>21.1</td><td>46</td></tr><tr><td>Failed breeders</td><td>82.0</td><td>50</td><td>18.0</td><td>11</td></tr></table> |
6db7c5b60d79444e261b4ba60c9170dbe30f2a51712edec65d2d91d3b5ab00bd.png | complex | <table><tr><td></td><td></td><td colspan="3">Medical claims with ICD-9-CM diagnosis codes</td></tr><tr><td>Characteristic</td><td>Total patients (<i>N </i>= 214)</td><td>Schizophrenia only (<i>n </i>= 44)</td><td>Bipolar disorder only (<i>n </i>= 162)</td><td>Schizophrenia and bipolar disorder (<i>n </i>= 8)</td></tr><... | <table><tr><td></td><td></td><td colspan="3">Medical claims with ICD-9-CM diagnosis codes</td></tr><tr><td>Characteristic</td><td>Total patients (N = 214)</td><td>Schizophrenia only (n = 44)</td><td>Bipolar disorder only (n = 162)</td><td>Schizophrenia and bipolar disorder (n = 8)</td></tr></table> | <table><tr><td colspan="5">Gender, n (%)</td></tr><tr><td>Male</td><td>74 (34.58)</td><td>24 (54.55)</td><td>48 (29.63)</td><td>2 (25.00)</td></tr><tr><td>Female</td><td>140 (65.42)</td><td>20 (45.45)</td><td>114 (70.37)</td><td>6 (75.00)</td></tr><tr><td>Age, mean (±SD, median)</td><td>43.02 (±12.84, 45)</td><td>46.30... |
1a71f4d402958090e7ae3a071581b7f2aba7e065a9b612e47258faf328603027.png | simple | <table><tr><td></td><td>Mean</td><td><i>SD</i></td><td>Range</td><td>Skewa</td><td>Kurtosisa</td></tr><tr><td>Adolescent self‐worth</td><td>26.85</td><td>4.53</td><td>16–46</td><td>−0.47 (−0.46)</td><td>3.31 (3.30)</td></tr><tr><td>Parent report parent–child closeness</td><td>39.09</td><td... | <table><tr><td></td><td>Mean</td><td>SD</td><td>Range</td><td>Skewa</td><td>Kurtosisa</td></tr><tr><td>Adolescent self‐worth</td><td>26.85</td><td>4.53</td><td>16–46</td><td>−0.47 (−0.46)</td><td>3.31 (3.30)</td></tr><tr><td>Parent report parent–child closeness</td><td>39.09</td><td>4.66</td><td>21–50</td><td>−0.09 (−0... | <table><tr><td></td><td>Mean</td><td>SD</td><td>Range</td><td>Skewa</td><td>Kurtosisa</td></tr><tr><td>Parent report expressions of affection</td><td>57.35</td><td>14.55</td><td>23–123</td><td>0.41 (0.45)</td><td>3.08 (3.34)</td></tr></table> |
dbaa204675920ea44999cd73b666703986ed0174a36e789e3d231c453a62e3f2.png | complex | <table><tr><td>Subthemes</td><td>Data extracts</td></tr><tr><td rowspan="5">4.1 Lack of empathy with the challenges of medication usage</td><td>‘ ... They don't <i>understand</i> that you are wearing stuff on your head that makes you smell like you're painting fences ... it's really <i>frustrating</i>, they [clin... | <table><tr><td>Subthemes</td><td>Data extracts</td></tr><tr><td rowspan="4">4.1 Lack of empathy with the challenges of medication usage</td><td>‘ ... They don't understand that you are wearing stuff on your head that makes you smell like you're painting fences ... it's really frustrating, they [clinicians] need to look... | <table><tr><td>4.1 Lack of empathy with the challenges of medication usage</td><td>‘Nobody has ever really asked me how I feel about my psoriasis or how I deal with my psoriasis. Or what my feelings are. Nobody has ever asked me that.’ [P15: using topical therapy and photochemotherapy]</td></tr><tr><td>4.2 Lack of supp... |
5d2d41c6f4ae8791cdc6afe50225d536d8527474780ba05495f9aee58ad25a86.png | complex | <table><tr><td>Anatomical region</td><td>L/R</td><td>Cluster level P(corrected)</td><td>Size (voxels)</td><td>Voxel level P (FDR-corrected)</td><td>Voxel level P (uncorrected)</td><td colspan="3">MNI (mm) x y z</td><td>Voxel Z</td></tr><tr><td>Limbic lobe uncus</td><td>Left</td><td>0.015</td><td>92</td><td>0.232</td><t... | <table><tr><td>Anatomical region</td><td>L/R</td><td>Cluster level P(corrected)</td><td>Size (voxels)</td><td>Voxel level P (FDR-corrected)</td><td>Voxel level P (uncorrected)</td><td colspan="3">MNI (mm) x y z</td><td>Voxel Z</td></tr><tr><td>Limbic lobe uncus</td><td>Left</td><td>0.015</td><td>92</td><td>0.232</td><t... | <table><tr><td>Middle Frontal gyrus</td><td>Left</td><td>0.083</td><td>66</td><td>0.018</td><td>0.000</td><td>−18</td><td>46</td><td>−14</td><td>5.21</td></tr><tr><td>Cerebellum posterior Lobe</td><td>Right</td><td>0.025</td><td>89</td><td>0.125</td><td>0.000</td><td>26</td><td>−34</td><td>−40</td><td>3.98</td></tr></t... |
6402e7c730ce33cc5a23a4b67f08f337e70167bd47f3422b013a8bea8b5d73f3.png | complex | <table><tr><td>Landscape characteristics</td><td>Definition</td></tr><tr><td colspan="2">Habitat types</td></tr><tr><td> Floodplain</td><td>Open, seasonally flooded grasslands</td></tr><tr><td> Grassland</td><td>Open, shrubbed, savannah grasslands</td></tr><tr><td> <i>Acacia</i> woodland</td><td>Open woodland with >... | <table><tr><td>Landscape characteristics</td><td>Definition</td></tr><tr><td colspan="2">Habitat types</td></tr><tr><td>Floodplain</td><td>Open, seasonally flooded grasslands</td></tr><tr><td>Grassland</td><td>Open, shrubbed, savannah grasslands</td></tr><tr><td>Acacia woodland</td><td>Open woodland with >70% Acacia sp... | <table><tr><td>Mopane woodland</td><td>Colophosphermum mopane dominated woodland</td></tr><tr><td colspan="2">Landscape metrics</td></tr><tr><td>Number of habitat patches (NP)</td><td>Measure of landscape fragmentation; metric equals the number of patches in the landscape. Value ranges from 1 if one patch covers entire... |
23ad2de9f65280a727fc73cbfe0d1b550503a0f753c6a4d2b23ef7a9a0926b18.png | simple | <table><tr><td>Clinical features</td><td>Patients at onset n</td><td>Cumulative number of patients at eight years n</td></tr><tr><td>Dactylitis</td><td>15</td><td>24</td></tr><tr><td>Nail pitting</td><td>10</td><td>18</td></tr><tr><td>Psoriasis</td><td>11</td><td>14</td></tr><tr><td>Psoriasis-like rash</td><td>6</td><t... | <table><tr><td>Clinical features</td><td>Patients at onset n</td><td>Cumulative number of patients at eight years n</td></tr><tr><td>Dactylitis</td><td>15</td><td>24</td></tr><tr><td>Nail pitting</td><td>10</td><td>18</td></tr><tr><td>Psoriasis</td><td>11</td><td>14</td></tr><tr><td>Psoriasis-like rash</td><td>6</td><t... | <table><tr><td>Enthesitis</td><td>37</td><td>41</td></tr></table> |
a669b21dfc592e48f2d11395f161f297d49b80605c7c6335219e3f3a169265a2.png | simple | <table><tr><td></td><td>Model definition(relevant year in brackets)</td><td>External data definition(data source in brackets)</td></tr><tr><td>Incidence</td><td>OUTCOME: Incidence of first AMI (2010)</td><td>Incidence of first AMI since 1998 (linked hospital episodes and mortality statistics, 2010).</td></tr><tr><td>Pr... | <table><tr><td></td><td>Model definition(relevant year in brackets)</td><td>External data definition(data source in brackets)</td></tr><tr><td>Incidence</td><td>OUTCOME: Incidence of first AMI (2010)</td><td>Incidence of first AMI since 1998 (linked hospital episodes and mortality statistics, 2010).</td></tr></table> | <table><tr><td></td><td>Model definition(relevant year in brackets)</td><td>External data definition(data source in brackets)</td></tr><tr><td>Prevalence</td><td>Prevalence of ever having had an AMI (2010)</td><td>Prevalence of ever having had a doctor-diagnosed AMI (Health Survey for England, 2011).</td></tr><tr><td>R... |
bd0da3a5954d55089f767a6fdf3ee47b8d0fc0a31edd2dc2a7acd7cdd4dfaac1.png | complex | <table><tr><td>Characteristics</td><td colspan="2">Potential patients (<i>n</i> = 10)</td><td colspan="2">Therapists (stage 1) (<i>n</i> = 4)</td><td colspan="2">Therapists (stage 3) (<i>n</i> = 5)</td></tr><tr><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td colspa... | <table><tr><td>Characteristics</td><td colspan="2">Potential patients (n = 10)</td><td colspan="2">Therapists (stage 1) (n = 4)</td><td colspan="2">Therapists (stage 3) (n = 5)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td colspan="7">Sex</td></tr><tr><td>Male</td><td>2<... | <table><tr><td>Characteristics</td><td colspan="2">Potential patients (n = 10)</td><td colspan="2">Therapists (stage 1) (n = 4)</td><td colspan="2">Therapists (stage 3) (n = 5)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td colspan="7">us therapy experience</td></tr><tr><... |
927313040d9521fb3ab3614c2e9c18d5ef6cddc1fcc136e98c2dc8756654ef67.png | complex | <table><tr><td>Gene </td><td> Organ</td><td> LPS</td><td> LPS + HOCbl</td><td><i>P</i> value (versus LPS)</td></tr><tr><td rowspan="2"> IL-1<i>β</i></td><td> Liver</td><td> − 8.30 ± 0.30</td><td> −10.6 ± 0.3*</td><td> 0.0056</td></tr><tr><td> Lung</td><td>2.70 ± 0.50</td><td> 2.1 ± ... | <table><tr><td>Gene</td><td>Organ</td><td>LPS</td><td>LPS + HOCbl</td><td>P value (versus LPS)</td></tr><tr><td rowspan="2">IL</td><td>Liver</td><td>− 8.30 ± 0.30</td><td>−10.6 ± 0.3*</td><td>0.0056</td></tr><tr><td></td><td>2.70 </td><td>2.1 </td><td></td></tr></table> | <table><tr><td>Gene</td><td>Organ</td><td>LPS</td><td>LPS + HOCbl</td><td>P value (versus LPS)</td></tr><tr><td>-1β</td><td>Lung</td><td>± 0.50</td><td>± 0.1</td><td>0.3046</td></tr><tr><td rowspan="2">TNF-α</td><td>Liver</td><td>− 86.90 ± 0.10</td><td>−68.6 ± 0.2*</td><td><0.0001</td></tr><tr><td>Lung</td><td>− 2.10 ±... |
3e531c72c19a9681b8c36bdeb3672637439a6e2b292daaac40993bb5e631f061.png | complex | <table><tr><td> </td><td colspan="2">Limbs = 421</td></tr><tr><td> </td><td>Mercury</td><td>Electronic device</td></tr><tr><td>Brachial SBP (mmHg), mean (SD)</td><td>140 (17)</td><td>140 (17)</td></tr><tr><td>Dorsalis pedis SBP (mmHg), mean (SD)</td><td>158 (30)</td><td>157 (30)</td></tr><tr><td>Posterior tibial SBP (m... | <table><tr><td></td><td colspan="2">Limbs = 421</td></tr><tr><td></td><td>Mercury</td><td>Electronic device</td></tr></table> | <table><tr><td>Brachial SBP (mmHg), mean (SD)</td><td>140 (17)</td><td>140 (17)</td></tr><tr><td>Dorsalis pedis SBP (mmHg), mean (SD)</td><td>158 (30)</td><td>157 (30)</td></tr><tr><td>Posterior tibial SBP (mmHg), mean (SD)</td><td>160 (31)</td><td>160 (30)</td></tr><tr><td>ABI, n (%)</td><td></td><td></td></tr><tr><td... |
a98679457aaf7c2472e7093de601c4684221775c484f12abd55eb1106ad9da58.png | complex | <table><tr><td rowspan="2">Symptoms</td><td rowspan="2">Prop</td><td rowspan="2">95% CI</td><td rowspan="2">I<sup>2</sup> (%)</td><td>Pop</td><td colspan="2">Summary of case report data</td></tr><tr><td>Studies/Patients</td><td><i>n</i></td><td>%</td></tr><tr><td>Falls</td><td>0.48</td><td>0.20, 0.77</td><td>84</td><td... | <table><tr><td rowspan="2">Symptoms</td><td rowspan="2">Prop</td><td rowspan="2">95% CI</td><td rowspan="2">I2 (%)</td><td>Pop</td><td colspan="2">Summary of case report data</td></tr><tr><td>Studies/Patients</td><td>n</td><td>%</td></tr><tr><td>Falls</td><td>0.48</td><td>0.20, 0.77</td><td>84</td><td>5/252</td><td>2</... | <table><tr><td rowspan="2">Symptoms</td><td rowspan="2">Prop</td><td rowspan="2">95% CI</td><td rowspan="2">I2 (%)</td><td>Pop</td><td colspan="2">Summary of case report data</td></tr><tr><td>Studies/Patients</td><td>n</td><td>%</td></tr><tr><td>ogical symptoms</td><td></td><td>.80</td><td></td><td>7</td><td>10</td><td... |
cbc0ca5de4e1baf5da4de4c802434d401a7349342e77971bf6411a9755ce44a7.png | complex | <table><tr><td rowspan="3">Chemicals</td><td colspan="4">24 h Area under the curve (mg/L-h)</td></tr><tr><td colspan="4">Metabolic scenario<sup>a</sup></td></tr><tr><td><i>E</i><sub>min⁡</sub></td><td><i>E</i><sub>max⁡</sub></td><td>LMCI</td><td>UMCI</td></tr><tr><td>Benzene</td><td>0.437</td><td>0.125</td>... | <table><tr><td rowspan="3">Chemicals</td><td colspan="4">24 h Area under the curve (mg/L-h)</td></tr><tr><td colspan="4">Metabolic scenarioa</td></tr><tr><td>Emin</td><td>Emax</td><td>LMCI</td><td>UMCI</td></tr><tr><td>Benzene</td><td>0.437</td><td>0.125</td><td>0.155</td><td>0.138</td></tr><tr><td>Bromochloromethane... | <table><tr><td rowspan="3">Chemicals</td><td colspan="4">24 h Area under the curve (mg/L-h)</td></tr><tr><td colspan="4">Metabolic scenarioa</td></tr><tr><td>Emin</td><td>Emax</td><td>LMCI</td><td>UMCI</td></tr><tr><td>Dichloromethane</td><td>0.65</td><td>0.157</td><td>0.206</td><td>0.174</td></tr><tr><td>Ethylbenzen... |
e617b10f722bffd13712518c8fbd656b2aaa591a889d1a5b7ed551f5a83b0273.png | simple | <table><tr><td>Trait<sup>1</sup></td><td>No. of records</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>BW6</td><td>511</td><td>802.33</td><td>133.58</td></tr><tr><td>BW12</td><td>511</td><td>2027.06</td><td>360.27</td></tr><tr><td>EP</td><td>511</td><td>66.57</td><td>1.82</td></tr><tr><td>BMP</td><td>511</td>... | <table><tr><td>Trait1</td><td>No. of records</td></tr><tr><td>BW6</td><td>511</td></tr><tr><td>BW12</td><td>511</td></tr><tr><td>EP</td><td>511</td></tr><tr><td>BMP</td><td>511</td></tr><tr><td>LMP</td><td>511</td></tr></table> | <table><tr><td>Mean</td><td>Standard deviation</td></tr><tr><td>802.33</td><td>133.58</td></tr><tr><td>2027.06</td><td>360.27</td></tr><tr><td>66.57</td><td>1.82</td></tr><tr><td>17.40</td><td>1.43</td></tr><tr><td>23.73</td><td>2.57</td></tr></table> |
8f7ccb0781a540eeabe0de464ddaf85b22e01da18a4fd4c7ac8349e6634dee26.png | simple | <table><tr><td>Host</td><td>Bacteria</td><td>Effective against</td><td>Active compound</td><td>Reference</td></tr><tr><td>Barnacle <i>B. amphitrite</i></td><td><i>Vibrio</i>, <i>Alteromonas</i>, <i>Alcaligenes</i>, <i>Flavobacterium</i>, and <i>Pseudomonas</i></td><td>Barnacle <i>B. amphitrite</i></td><td>?</td><td>Mar... | <table><tr><td>Host</td><td>Bacteria</td><td>Effective against</td><td>Active compound</td><td>Reference</td></tr><tr><td>Barnacle B. amphitrite</td><td>Vibrio, Alteromonas, Alcaligenes, Flavobacterium, and Pseudomonas</td><td>Barnacle B. amphitrite</td><td>?</td><td>Mary et al. (1993)</td></tr><tr><td>Algae, sponges, ... | <table><tr><td>Brown alga Fucus serratus, F. vesiculosus, and the red alga Polysiphonia stricta</td><td>Natural communities, Photobacterium halotolerans and Ulvibacter litoralis, Shewanella basaltis, Pseudoalteromonas arctica, Shewanella baltica, and Bacillus foraminis</td><td>Barnacle Amphibalanus improvisus</td><td>?... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.